{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":51,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":51,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"5ce50c55e25f","filters":{"venue":"Immunotherapy"}},"results":[{"id":"W2156823146","doi":"10.2217/imt.13.123","title":"Evolution of Oncolytic Viruses: Novel Strategies for Cancer Treatment","year":2013,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"","keywords":"Oncolytic virus; Biology; Immune system; Cancer; Virotherapy; Immunotherapy; Virus; Immunology; Immunogenic cell death; Innate immune system; Virology; Cancer research; Genetics","authors":[{"name":"Matthew J. Atherton","is_ca":true},{"name":"Brian D. Lichty","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08584175302475491,"gpt":0.4154220359967364,"spread":0.3295802829719815,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007260868,0.0004160393,0.0006100194,0.0007772097,0.0002340798,0.001118462,0.00049341,0.0007640983,0.001975568],"category_scores_gemma":[0.0004323303,0.0002430064,0.000630866,0.0004406271,0.0005470797,0.001251718,0.000713213,0.002354577,0.0009789743],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007768128,"about_ca_system_score_gemma":0.0004733322,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006064519,"about_ca_topic_score_gemma":0.0008906242,"domain_scores_codex":[0.9997098,0.0000756364,0.00001536014,0.00005078128,0.000106517,0.00004181096],"domain_scores_gemma":[0.9998794,0.00003535209,0.00001946223,0.000009995507,0.00003480693,0.00002109601],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004494197,0.0003651633,0.0009747113,0.004799292,0.0002515541,0.0006173018,0.0004384915,0.003221711,0.199396,0.05856406,0.02219062,0.7087317],"study_design_scores_gemma":[0.0000965563,0.0009354092,0.001000028,0.0007789161,0.0001418246,0.001688335,0.00009471898,0.002083839,0.04484671,0.01388395,0.9343925,0.00005734104],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.013588,0.9403334,0.02944681,0.003582263,0.001270273,0.0001227864,0.0002329421,0.000195474,0.01122802],"genre_scores_gemma":[0.1003568,0.8574535,0.02595635,0.002699578,0.0007816436,0.000216618,0.0006102905,0.00007051806,0.01185474],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.001975568,"threshold_uncertainty_score":0.006608903,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2135975326","doi":"10.2217/imt.14.66","title":"Vedolizumab for Ulcerative Colitis and Crohn’s Disease: Results and Implications of GEMINI Studies","year":2014,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Vedolizumab; Ulcerative colitis; Medicine; Inflammatory bowel disease; Internal medicine; Gastroenterology; Crohn's disease; Placebo; Maintenance therapy; Disease; Immunology; Pathology; Chemotherapy","authors":[{"name":"Mindy Lam","is_ca":true},{"name":"Brian Bressler","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01453315354671545,"gpt":0.2979342926323513,"spread":0.2834011390856359,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0214827,0.0008314984,0.001762526,0.0008674457,0.0003398223,0.001761206,0.0008658783,0.001129163,0.002401843],"category_scores_gemma":[0.01028517,0.0002397006,0.002072757,0.001215895,0.001011703,0.001487154,0.0005137388,0.00176618,0.0005641177],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001593438,"about_ca_system_score_gemma":0.001738373,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002048548,"about_ca_topic_score_gemma":0.003142225,"domain_scores_codex":[0.9953346,0.002657627,0.0005702265,0.0003236496,0.000769034,0.0003449311],"domain_scores_gemma":[0.9866396,0.007193908,0.001465571,0.0006645934,0.002775785,0.001260552],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.07387974,0.004353695,0.01817662,0.005454854,0.003482507,0.0004978972,0.0005771813,0.0009679472,0.0132848,0.003613051,0.009948567,0.8657631],"study_design_scores_gemma":[0.0444488,0.1745936,0.2640235,0.0126118,0.02015132,0.002552509,0.001273379,0.001541799,0.02049295,0.004984508,0.4530711,0.0002548043],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.1267408,0.8365893,0.0009180978,0.01259193,0.0007253193,0.0005819043,0.0009703054,0.0000396357,0.02084258],"genre_scores_gemma":[0.4885728,0.4818422,0.004189312,0.01304971,0.002660941,0.0004631309,0.002574055,0.00009472828,0.006553219],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.0214827,"threshold_uncertainty_score":0.1136128,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2133116144","doi":"10.2217/imt.09.40","title":"Immunotherapy as a Strategy for Treatment of Leishmaniasis: a Review of the Literature","year":2009,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Research on Leishmaniasis Studies","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"Canadian Institutes of Health Research; Manitoba Health Research Council","keywords":"Leishmaniasis; Medicine; Immunotherapy; Immunology; Intensive care medicine; Drug resistance; Drug; Immune system; Biology; Pharmacology","authors":[{"name":"Ifeoma Okwor","is_ca":true},{"name":"Jude E. Uzonna","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0728975426469038,"gpt":0.4127452399516908,"spread":0.339847697304787,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004036874,0.0008795287,0.00164638,0.003160593,0.0002872857,0.0008325906,0.0008372384,0.0008252131,0.00457113],"category_scores_gemma":[0.0005793019,0.0002285712,0.0004406284,0.003670543,0.000430209,0.001304186,0.0003751549,0.0008902682,0.001799491],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000402187,"about_ca_system_score_gemma":0.0009011629,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008902938,"about_ca_topic_score_gemma":0.001671881,"domain_scores_codex":[0.9998307,0.00003125228,0.00003753866,0.00003078847,0.00005865874,0.00001100829],"domain_scores_gemma":[0.9997126,0.0001445102,0.00005454836,0.000007189258,0.00005687098,0.00002420532],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0001074534,0.0001377425,0.0003190315,0.04603788,0.0001376661,0.0006891239,0.00008840205,0.0003200858,0.001950647,0.001570734,0.02592536,0.9227159],"study_design_scores_gemma":[0.00005438843,0.0002522938,0.002586743,0.01525308,0.0004632415,0.007731859,0.0002220491,0.0001338628,0.0007644411,0.001894887,0.9706095,0.00003376977],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001197661,0.999144,0.00005843838,0.0001092027,0.00009738342,0.000004169389,0.00001065906,0.000003676856,0.000452642],"genre_scores_gemma":[0.0004560601,0.9990664,0.0001413121,0.00007557878,0.00008409667,0.000003974528,0.00001190296,5.530995e-7,0.0001601838],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00457113,"threshold_uncertainty_score":0.01529199,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1982443638","doi":"10.2217/imt.14.108","title":"Lentiviral Vectors in Cancer Immunotherapy","year":2015,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; Canada Research Chairs; University of Toronto","funders":"","keywords":"Immunotherapy; Viral vector; Cancer immunotherapy; Cancer; Insertional mutagenesis; Immune system; Genetic enhancement; Vector (molecular biology); Medicine; Computational biology; Gene delivery; Effector; Clinical trial; Biology; Immunology; Cancer research; Bioinformatics; Gene; Genome; Genetics","authors":[{"name":"Robyn A. A. Oldham","is_ca":true},{"name":"Elliot Berinstein","is_ca":true},{"name":"Jeffrey A. Medin","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03454148207282977,"gpt":0.3433136183843259,"spread":0.3087721363114962,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001096649,0.0005795946,0.0006992779,0.0009628517,0.000351016,0.001391834,0.0005872992,0.001111032,0.00222542],"category_scores_gemma":[0.000471394,0.000344668,0.0003490261,0.0009539211,0.0007344711,0.001143624,0.0006680507,0.002783566,0.002007171],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00083508,"about_ca_system_score_gemma":0.0007008534,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004596315,"about_ca_topic_score_gemma":0.0004034404,"domain_scores_codex":[0.999469,0.0001221978,0.0000453324,0.00005763568,0.0002619973,0.00004393142],"domain_scores_gemma":[0.9998474,0.00004850893,0.0000327609,0.00001604812,0.00003151498,0.00002375883],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000245293,0.0002333588,0.0005116767,0.001933275,0.00006352714,0.0006951512,0.0003487914,0.001493929,0.2129096,0.103983,0.02236635,0.655216],"study_design_scores_gemma":[0.0001033079,0.0006177598,0.0005650499,0.000595957,0.00006550247,0.001951865,0.00005884463,0.001728948,0.09536043,0.02140051,0.8775003,0.00005151615],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01507908,0.8273147,0.1086923,0.004609923,0.002410955,0.0003236113,0.0004881438,0.001075158,0.04000623],"genre_scores_gemma":[0.1538858,0.7066689,0.08472737,0.003595942,0.002132198,0.0006223167,0.001572669,0.0002861305,0.04650867],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00222542,"threshold_uncertainty_score":0.007444799,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4376640915","doi":"10.2217/imt-2022-0139","title":"Association of Circadian Timing of Initial Infusions of Immune Checkpoint Inhibitors with Survival in Advanced Melanoma","year":2023,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Kingston Health Sciences Centre","funders":"","keywords":"Circadian rhythm; Medicine; Melanoma; Immune system; Immune checkpoint; Association (psychology); Oncology; Internal medicine; Immunotherapy; Immunology; Cancer research; Psychology","authors":[{"name":"Cynthia Yeung","is_ca":true},{"name":"Adi Kartolo","is_ca":true},{"name":"Justin Tong","is_ca":true},{"name":"Wilma M. Hopman","is_ca":true},{"name":"Tara Baetz","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01719611694627355,"gpt":0.3009920710369966,"spread":0.2837959540907231,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005791305,0.000130145,0.0001814036,0.0001710992,0.0001348475,0.0003163726,0.0001106472,0.0001253733,0.0008009925],"category_scores_gemma":[0.001568018,0.00009570889,0.0002225812,0.0002290297,0.0001060679,0.000156354,0.0001677564,0.0002467842,0.00008749232],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002079901,"about_ca_system_score_gemma":0.0001897147,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007692237,"about_ca_topic_score_gemma":0.001077154,"domain_scores_codex":[0.9998001,0.00005995914,0.00001833316,0.00005225452,0.00003311081,0.00003619178],"domain_scores_gemma":[0.9986874,0.0002365267,0.0008094429,0.00008724597,0.00008023759,0.00009906205],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001677717,0.00005893916,0.9829441,0.00003661742,0.0001085396,0.00004171265,0.0000415549,0.0001956162,0.002324145,0.00002684624,0.0001626309,0.01238157],"study_design_scores_gemma":[0.00001811644,0.0003848715,0.9982985,0.000006219795,0.00004610152,0.0001531249,0.00003151331,0.0002878873,0.0004131109,0.00002387704,0.0003338156,0.000002903506],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997458,0.001752224,0.0002874782,0.0000347186,0.0000179214,0.000005503977,0.000134817,0.000004992228,0.0003044165],"genre_scores_gemma":[0.9995292,0.0002138256,0.00009030027,0.00001345825,0.00001199858,0.000003171838,0.00008183555,0.000001505126,0.00005462059],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0008009925,"threshold_uncertainty_score":0.003062785,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2978287760","doi":"10.2217/imt-2018-0035","title":"Atezolizumab-Induced Sarcoid-Like Granulomatous Reaction in a Patient with Urothelial Cell Carcinoma","year":2018,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Sarcoidosis and Beryllium Toxicity Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa","funders":"","keywords":"Atezolizumab; Medicine; Sarcoidosis; Malignancy; Mediastinal lymph node; Lymph node; Lymph node biopsy; Biopsy; Mediastinal lymphadenopathy; Pathology; Carcinoma; Radiology; Immunotherapy; Cancer; Internal medicine; Nivolumab; Metastasis","authors":[{"name":"Michael A. Mitchell","is_ca":true},{"name":"Kevin T. Hogan","is_ca":true},{"name":"Kayvan Amjadi","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0186478648614335,"gpt":0.277726634204796,"spread":0.2590787693433625,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004132235,0.0006529385,0.0009461598,0.0007974009,0.001353708,0.0007662865,0.0003278202,0.002426224,0.0013938],"category_scores_gemma":[0.001991171,0.0005277261,0.0005732534,0.0004860508,0.0006724842,0.0007631509,0.0005091667,0.001248616,0.0004178406],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00056349,"about_ca_system_score_gemma":0.0003336208,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000798311,"about_ca_topic_score_gemma":0.0008546623,"domain_scores_codex":[0.9997081,0.00005221997,0.00004279926,0.00006708541,0.00003567878,0.00009408822],"domain_scores_gemma":[0.9990535,0.000390011,0.0001309083,0.00008104496,0.00005207551,0.0002924554],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"case_report","study_design_scores_codex":[0.000206639,0.000146888,0.0349102,0.00004640046,0.00001648179,0.9594918,0.0004162102,0.0001062987,0.002001393,0.0001257787,0.0002010768,0.002330705],"study_design_scores_gemma":[0.0000817311,0.0005065771,0.03344425,0.0000244865,0.0000414932,0.9633219,0.0001792871,0.0005075744,0.0008219259,0.0001336379,0.0009213235,0.00001584248],"study_design_candidate":"case_report","study_design_consensus":"case_report","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905343,0.002175493,0.0007183067,0.001047888,0.000110151,0.00007434474,0.00006760423,0.00005289835,0.005218904],"genre_scores_gemma":[0.9988041,0.0003247898,0.0001290003,0.0002354942,0.0001093638,0.000005077833,0.00002688995,0.000004100348,0.0003611797],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002426224,"threshold_uncertainty_score":0.004662693,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1993673970","doi":"10.2217/imt.14.122","title":"Bidirectional Interactions of NK Cells and Dendritic Cells in Immunotherapy: Current and Future Perspective","year":2015,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":25,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; Apotex (Canada)","funders":"","keywords":"Crosstalk; Immunotherapy; Immune system; Tumor microenvironment; Cancer immunotherapy; Dendritic cell; Innate immune system; Biology; Acquired immune system; Cell biology; Immunology; Physics","authors":[{"name":"Sajid Mahmood","is_ca":true},{"name":"Deepak Upreti","is_ca":true},{"name":"Ibrahim Sow","is_ca":true},{"name":"Abdulaziz Alamri","is_ca":true},{"name":"Saravanan Nandagopal","is_ca":true},{"name":"Sam KP Kung","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02513291453161458,"gpt":0.3209390407875841,"spread":0.2958061262559695,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006402225,0.0006767081,0.001005179,0.001287496,0.0002522608,0.001074779,0.000685429,0.001342729,0.002985699],"category_scores_gemma":[0.0005335456,0.0002448369,0.0004153251,0.001464073,0.0004859322,0.002007238,0.0007789492,0.001933493,0.001696383],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005727196,"about_ca_system_score_gemma":0.001056617,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004797815,"about_ca_topic_score_gemma":0.000864935,"domain_scores_codex":[0.9998348,0.00003228052,0.00002642707,0.00002904711,0.00005502351,0.00002238172],"domain_scores_gemma":[0.9996846,0.0001439017,0.00004086148,0.000009873976,0.00007645747,0.00004426264],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007169601,0.00006898464,0.0002025503,0.01271096,0.0000624051,0.0001948032,0.00006848351,0.0003796696,0.002863269,0.006838526,0.03403308,0.9425056],"study_design_scores_gemma":[0.00001027644,0.00006525731,0.000434977,0.002077867,0.00006969158,0.001123636,0.00005695715,0.00009763592,0.0004757837,0.003056339,0.9925154,0.00001633601],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007567711,0.9983799,0.0001653888,0.0003840963,0.0003472519,0.000002247874,0.000006472089,0.000005772348,0.000633068],"genre_scores_gemma":[0.0005914814,0.9979814,0.0002391121,0.0002815809,0.0004066646,0.000004582677,0.00001400448,0.000001328631,0.0004798279],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002985699,"threshold_uncertainty_score":0.009988129,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2070064055","doi":"10.2217/imt.09.80","title":"Immunization of Newborn and Adult Mice with Low Numbers of BCG Leads to Th1 Responses, Th1 Imprints and Enhanced Protection Upon BCG Challenge","year":2009,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University; University of Saskatchewan","funders":"Canadian Institutes of Health Research","keywords":"Vaccination; Medicine; Immunization; Immunology; Immune system; Context (archaeology); Tuberculosis; Immunity; Biology; Pathology","authors":[{"name":"Tadele G. Kiros","is_ca":true},{"name":"Carl A. Power","is_ca":false},{"name":"Guojian Wei","is_ca":true},{"name":"Peter A. Bretscher","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01353806602832203,"gpt":0.3039691230209426,"spread":0.2904310569926206,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006149895,0.0003000491,0.000448049,0.0003017972,0.0001625646,0.0002270722,0.0002068019,0.0003882084,0.001271017],"category_scores_gemma":[0.0003160883,0.000170524,0.000156201,0.0001267514,0.0002871704,0.0002739331,0.0001754952,0.001015769,0.0002870335],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001757384,"about_ca_system_score_gemma":0.0001591788,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002343967,"about_ca_topic_score_gemma":0.0004423926,"domain_scores_codex":[0.9997665,0.00007059261,0.00002487372,0.00003560889,0.0000310382,0.00007132801],"domain_scores_gemma":[0.9996892,0.00004664805,0.00007268766,0.0000498536,0.00001730265,0.0001243355],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.008381435,0.001620232,0.003565659,0.0001290747,0.00002669316,0.0001477701,0.0001135651,0.0001554855,0.9712061,0.0002449478,0.0003264126,0.0140826],"study_design_scores_gemma":[0.0009532743,0.04940495,0.04997075,0.000048839,0.0001157452,0.00137092,0.00009397136,0.001013185,0.8922761,0.0002160083,0.004515061,0.00002124499],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968753,0.001127308,0.0007224353,0.0001011475,0.00003211383,0.00003818027,0.0001831049,0.00004372458,0.0008766258],"genre_scores_gemma":[0.9962733,0.0006589125,0.0008375914,0.0001558782,0.00003535678,0.00005136284,0.0002671742,0.000009789643,0.001710671],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001271017,"threshold_uncertainty_score":0.004251957,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2162451701","doi":"10.2217/imt.14.7","title":"Alemtuzumab for the Treatment of Relapsing–Remitting Multiple Sclerosis","year":2014,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Alemtuzumab; Relapsing remitting; Multiple sclerosis; Medicine; Fingolimod; Oncology; Internal medicine; Immunology","authors":[{"name":"Carrie M. Hersh","is_ca":false},{"name":"Jeffrey Cohen","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2022904802481968,"gpt":0.4048349850202537,"spread":0.2025445047720569,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006610035,0.0008070624,0.00167227,0.004100539,0.0002989991,0.0007481669,0.0007497789,0.0008777986,0.005156467],"category_scores_gemma":[0.0007317973,0.0002384137,0.0008546009,0.003675471,0.0003594422,0.0008837773,0.0007303471,0.001350348,0.002002389],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005255057,"about_ca_system_score_gemma":0.001032283,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001273238,"about_ca_topic_score_gemma":0.002237729,"domain_scores_codex":[0.9997206,0.00006291978,0.00005352904,0.00003808218,0.0001045783,0.00002019378],"domain_scores_gemma":[0.9997628,0.0001112149,0.00005367014,0.000007412842,0.00004683818,0.00001812501],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001298827,0.00007965386,0.0001239752,0.04423726,0.000259034,0.0001789986,0.00006750484,0.0001920846,0.001415923,0.001555516,0.02042854,0.9313317],"study_design_scores_gemma":[0.00008407173,0.0001326278,0.001108889,0.01339892,0.0004943048,0.001923941,0.00006115468,0.00005493069,0.0005814646,0.001341346,0.980799,0.00001933795],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005882563,0.9994152,0.00003855415,0.00006041098,0.00004100421,0.000005163488,0.00001146591,0.000003973857,0.0003654967],"genre_scores_gemma":[0.0005896103,0.9988808,0.0001026544,0.00008590605,0.00003997136,0.000006133216,0.00002197793,9.418176e-7,0.0002720229],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005156467,"threshold_uncertainty_score":0.01725006,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2007718183","doi":"10.2217/imt.13.81","title":"Ustekinumab for the Treatment of Crohn‘s Disease","year":2013,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"Genentech; ActoGeniX; Zalicus; Janssen Biotech; Wyeth","keywords":"Ustekinumab; Medicine; Crohn's disease; Psoriasis; Monoclonal antibody; Disease; Immunology; Immune system; Monoclonal; Crohn disease; Inflammatory bowel disease; Antibody; Tumor necrosis factor alpha; Internal medicine; Adalimumab","authors":[{"name":"Reena Khanna","is_ca":true},{"name":"Brian G. Feagan","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09589915221036092,"gpt":0.4150780252147817,"spread":0.3191788730044207,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004131566,0.0006312164,0.001083908,0.002251131,0.0002452661,0.0005746035,0.0005791862,0.0007866035,0.003911452],"category_scores_gemma":[0.0004155278,0.0001816322,0.0005171411,0.002019613,0.0003224488,0.0007806363,0.0005183057,0.001544431,0.002837969],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003447694,"about_ca_system_score_gemma":0.0005194264,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005485924,"about_ca_topic_score_gemma":0.001389316,"domain_scores_codex":[0.9998057,0.00003403692,0.00002758771,0.00002840503,0.00008693025,0.00001738738],"domain_scores_gemma":[0.9998528,0.00006030684,0.00003209294,0.000004584332,0.00003214476,0.00001809949],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008090131,0.00006442059,0.0001126116,0.00777321,0.00007096579,0.0001652689,0.0000333576,0.0001220333,0.00158737,0.000856846,0.01688661,0.9722464],"study_design_scores_gemma":[0.00005690441,0.0001506304,0.001003944,0.003537149,0.0001478714,0.00228818,0.00004838814,0.00006564408,0.000674404,0.0008935598,0.9911179,0.00001535611],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001994222,0.9983504,0.0000836723,0.0001486691,0.0001079732,0.000005369563,0.00001274804,0.000008754055,0.001082985],"genre_scores_gemma":[0.001061238,0.9978389,0.0001539111,0.0001596604,0.00009789615,0.00000591398,0.00002818772,0.000001606881,0.000652675],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003911452,"threshold_uncertainty_score":0.01308513,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3047233339","doi":"10.2217/imt-2020-0158","title":"Romosozumab in the Treatment of Osteoporosis","year":2020,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Impact; McMaster University","funders":"Amgen","keywords":"Sclerostin; Osteoporosis; Medicine; Bone resorption; Bone mineral; Bone Density Conservation Agents; Wnt signaling pathway; Internal medicine; Bioinformatics; Chemistry; Signal transduction; Biology; Biochemistry","authors":[{"name":"Alexandra Kobza","is_ca":true},{"name":"Αλεξάνδρα Παπαϊωάννου","is_ca":true},{"name":"Arthur Lau","is_ca":true},{"name":"Jonathan D. Adachi","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0488655667525898,"gpt":0.3460848872339871,"spread":0.2972193204813973,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002864081,0.0002466219,0.0004752718,0.0006424231,0.0001523952,0.0003045944,0.0002446218,0.000468479,0.001959086],"category_scores_gemma":[0.0002902513,0.00007462501,0.0003149861,0.0003841454,0.0001910648,0.0002574656,0.0002563208,0.001264238,0.000728665],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002749921,"about_ca_system_score_gemma":0.0002716921,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005512218,"about_ca_topic_score_gemma":0.001447831,"domain_scores_codex":[0.9998749,0.00003115812,0.0000151823,0.0000182286,0.00004607596,0.00001443195],"domain_scores_gemma":[0.9999396,0.00002085288,0.00001645708,0.000001631076,0.00001303058,0.0000084766],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004764094,0.000229191,0.0003859873,0.005485596,0.0001118884,0.0007065728,0.00007541983,0.0003516822,0.01349705,0.003496517,0.02215114,0.9530325],"study_design_scores_gemma":[0.0004198571,0.001069912,0.004312176,0.002644867,0.0002630106,0.006685684,0.00005726107,0.0003715601,0.004454758,0.003287335,0.9763969,0.0000367319],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003107372,0.9904619,0.0004403268,0.00128167,0.0002894019,0.00001966509,0.00004027744,0.0000300167,0.004329397],"genre_scores_gemma":[0.03508782,0.9572977,0.001409522,0.00161473,0.000717059,0.00003958901,0.0001358706,0.000006176396,0.003691501],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.001959086,"threshold_uncertainty_score":0.006553769,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4408003542","doi":"10.1080/1750743x.2025.2464528","title":"ROCKET: a phase 3 program evaluating the efficacy and safety of rocatinlimab in moderate-to-severe atopic dermatitis","year":2025,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Innovaderm (Canada)","funders":"Amgen","keywords":"Atopic dermatitis; Medicine; Dermatology; Rocket (weapon); Engineering; Aeronautics","authors":[{"name":"Emma Guttman‐Yassky","is_ca":false},{"name":"Eric L. Simpson","is_ca":false},{"name":"Robert Bissonnette","is_ca":true},{"name":"Lawrence F. Eichenfield","is_ca":false},{"name":"Kenji Kabashima","is_ca":false},{"name":"Paula Carolina Luna","is_ca":false},{"name":"Jana Hercogová","is_ca":false},{"name":"Lynda Spelman","is_ca":false},{"name":"Margitta Worm","is_ca":false},{"name":"Ehsanollah Esfandiari","is_ca":false},{"name":"Takahiro Arai","is_ca":false},{"name":"Hirotaka Mano","is_ca":false},{"name":"Prista Charuworn","is_ca":false},{"name":"Andrea Wang","is_ca":false},{"name":"Greg Kricorian","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02051525263557304,"gpt":0.3718269398653076,"spread":0.3513116872297346,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002998478,0.00134752,0.001119552,0.0004637261,0.000418426,0.001118778,0.00103466,0.001116548,0.008013604],"category_scores_gemma":[0.001071141,0.0003428434,0.001430761,0.0003416582,0.0006235951,0.0009161784,0.0004491555,0.003118177,0.001583562],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009210706,"about_ca_system_score_gemma":0.002116284,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009515012,"about_ca_topic_score_gemma":0.003095512,"domain_scores_codex":[0.999487,0.0002440682,0.00002284903,0.00006640566,0.00007137931,0.0001082066],"domain_scores_gemma":[0.9994681,0.00008497094,0.0001165146,0.00004583278,0.00007929193,0.0002052131],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.423326,0.08509511,0.0115173,0.003476603,0.003232424,0.0006206543,0.0004695124,0.006148054,0.09167109,0.001886929,0.06849275,0.3040635],"study_design_scores_gemma":[0.5949134,0.3309817,0.0204991,0.0003414799,0.001286323,0.001077046,0.0001666335,0.003838485,0.01367377,0.0008647682,0.03228221,0.00007519569],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9357175,0.01116674,0.003138912,0.003111587,0.0007094993,0.01971198,0.0103799,0.0009359327,0.01512792],"genre_scores_gemma":[0.9258702,0.007577103,0.008996492,0.005267182,0.0004057168,0.01879282,0.0171171,0.0002348991,0.01573839],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008013604,"threshold_uncertainty_score":0.0268082,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2550798570","doi":"10.2217/imt-2016-0079","title":"Double-Blind, Placebo-Controlled, 1:1 Randomized Phase III Clinical Trial Of Immunoxel Honey Lozenges as an Adjunct Immunotherapy in 269 Patients with Pulmonary Tuberculosis","year":2016,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Bee Products Chemical Analysis","field":"Agricultural and Biological Sciences","cited_by":14,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Adjunct; Medicine; Placebo; Double blind; Lozenge; Clinical trial; Immunotherapy; Tuberculosis; Randomized controlled trial; Phases of clinical research; Pulmonary tuberculosis; Internal medicine; Pathology; Cancer","authors":[{"name":"Uyanga Batbold","is_ca":false},{"name":"Dmytro Butov","is_ca":false},{"name":"Galyna A Kutsyna","is_ca":false},{"name":"Narantsetseg Damdinpurev","is_ca":false},{"name":"Elena A. Grinishina","is_ca":false},{"name":"Otgonbayar Mijiddorj","is_ca":false},{"name":"Mikola E Kovolev","is_ca":false},{"name":"Khaliunaa Baasanjav","is_ca":false},{"name":"Tetiana Butova","is_ca":false},{"name":"Munkhburam Sandagdorj","is_ca":false},{"name":"Ochirbat Batbold","is_ca":false},{"name":"Ariungerel Tseveendorj","is_ca":false},{"name":"Erkhemtsetseg Chunt","is_ca":false},{"name":"Svetlana I Zaitzeva","is_ca":false},{"name":"Hanna Stepanenko","is_ca":false},{"name":"Natalia Makeeva","is_ca":false},{"name":"Igor V Mospan","is_ca":false},{"name":"Volodymyr S. Pylypchuk","is_ca":false},{"name":"John L Rowe","is_ca":false},{"name":"Peter S. Nyasulu","is_ca":false},{"name":"Vichai Jirathitikal","is_ca":true},{"name":"Allen I. Bain","is_ca":true},{"name":"Marina G Tarakanovskaya","is_ca":false},{"name":"Aldar S. Bourinbaiar","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02854180778147574,"gpt":0.3012245799919154,"spread":0.2726827722104397,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001350491,0.001723747,0.003352325,0.0003859166,0.0006807753,0.0009206131,0.0009847099,0.001640731,0.007612016],"category_scores_gemma":[0.001398015,0.0009268643,0.000797031,0.0003345674,0.001463663,0.0008785483,0.0004965388,0.00233079,0.00129142],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005947644,"about_ca_system_score_gemma":0.001167998,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005886551,"about_ca_topic_score_gemma":0.001596908,"domain_scores_codex":[0.9995326,0.000216986,0.00003060642,0.00008974785,0.00004023974,0.00008984709],"domain_scores_gemma":[0.9992779,0.0001796257,0.0001554491,0.00004804281,0.00005002493,0.0002889273],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9701989,0.0146114,0.0006916285,0.0004086604,0.000192027,0.0000451387,0.00004815467,0.0001601486,0.003800199,0.00005990449,0.0005546704,0.00922921],"study_design_scores_gemma":[0.8835363,0.1144206,0.001168746,0.00001366973,0.00007981253,0.00002428735,0.00001726355,0.0001868681,0.0002193726,0.00004655877,0.000279069,0.000007453638],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9885436,0.002050344,0.0006150472,0.0004770262,0.0004941841,0.006183198,0.0005513313,0.00009256108,0.000992544],"genre_scores_gemma":[0.9831457,0.001900433,0.001669537,0.001071662,0.0007106088,0.007574455,0.0007017124,0.00002047921,0.003205505],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007612016,"threshold_uncertainty_score":0.02546471,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2921861485","doi":"10.2217/imt-2018-0186","title":"Toxicity Patterns Associated with Chemotherapy/Immune Checkpoint Inhibitor Combinations: A Meta-Analysis","year":2019,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Meta-analysis; Chemotherapy; Toxicity; Medicine; Immune checkpoint; Immune system; Immunotherapy; Oncology; Immunology; Internal medicine","authors":[{"name":"Omar Abdel‐Rahman","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0886360825971064,"gpt":0.3486131514574846,"spread":0.2599770688603782,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01016782,0.002589456,0.01148049,0.005504114,0.0003921842,0.002497076,0.001341784,0.001411142,0.002916934],"category_scores_gemma":[0.01733529,0.00112097,0.03626701,0.006152065,0.0003561516,0.001157083,0.001090333,0.001430688,0.000265091],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00145576,"about_ca_system_score_gemma":0.001373842,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002911998,"about_ca_topic_score_gemma":0.006753541,"domain_scores_codex":[0.9931135,0.00355367,0.00169958,0.0008171921,0.0006334778,0.0001825458],"domain_scores_gemma":[0.9864225,0.009986774,0.002291747,0.0004197207,0.0007416336,0.0001376251],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.002072573,0.00002556632,0.008111488,0.1518207,0.8163368,0.0001264978,0.00003253772,0.00084033,0.0002725912,0.0001057236,0.0006675666,0.01958759],"study_design_scores_gemma":[0.0003454389,0.0001680505,0.004852484,0.008738088,0.9835992,0.0001613655,0.00001987814,0.0002201144,0.0001072764,0.0001909575,0.001582444,0.00001470417],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.005114365,0.9933532,0.0005177046,0.0001524319,0.00008063258,0.00009037512,0.0004346802,0.00001376877,0.0002427092],"genre_scores_gemma":[0.2107092,0.7838062,0.002304943,0.0008780832,0.0002942115,0.0004021606,0.00117638,0.0000413692,0.0003875692],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01148049,"threshold_uncertainty_score":0.05377322,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2043429701","doi":"10.2217/imt.13.141","title":"Employing an IL-23 p19 Vaccine to Block IL-23 Ameliorates Chronic Murine Colitis","year":2013,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"Canadian Institutes of Health Research","keywords":"Colitis; Medicine; Immunology; In vivo; Interleukin 23; Splenocyte; Pathogenesis; Inflammatory bowel disease; In vitro; Peptide vaccine; Interleukin; Antibody; Cytokine; Disease; Internal medicine; Epitope; Biology","authors":[{"name":"Qingdong Guan","is_ca":true},{"name":"Helen A Burtnick","is_ca":true},{"name":"Gefei Qing","is_ca":true},{"name":"Carolyn R. Weiss","is_ca":true},{"name":"G. Allan","is_ca":true},{"name":"Yanbing Ma","is_ca":false},{"name":"Richard Warrington","is_ca":true},{"name":"Zhikang Peng","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.006629204937353886,"gpt":0.248728499099141,"spread":0.2420992941617871,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001260758,0.0005179632,0.0003299023,0.0002966848,0.00009997616,0.0002168256,0.000213805,0.0003909891,0.0008994683],"category_scores_gemma":[0.00009494132,0.0001069739,0.0002283392,0.0001244238,0.000241291,0.0002080578,0.0001367261,0.0009235787,0.000252539],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001525402,"about_ca_system_score_gemma":0.000258456,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002258811,"about_ca_topic_score_gemma":0.0003970717,"domain_scores_codex":[0.9998978,0.00001137696,0.00001009812,0.00001686174,0.00002647028,0.00003734941],"domain_scores_gemma":[0.9999022,0.00001271973,0.00003579467,0.000008525087,0.00001134054,0.00002941636],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002669086,0.0004483113,0.0001520303,0.00008475862,0.000009863676,0.00006736165,0.000008950507,0.0002089656,0.9947798,0.00006662991,0.00006363372,0.003842772],"study_design_scores_gemma":[0.0002523886,0.006666777,0.002146406,0.00002433994,0.00007450716,0.0003814643,0.00001667699,0.001588703,0.9860944,0.00007088325,0.002677373,0.000006181088],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991569,0.001772036,0.005048226,0.0001862219,0.0001035718,0.0001175316,0.0001525853,0.0001709103,0.0008798979],"genre_scores_gemma":[0.9909073,0.001751356,0.005142533,0.0001200556,0.00005980076,0.0001107465,0.0003243734,0.00002321093,0.001560551],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0008994683,"threshold_uncertainty_score":0.003009021,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4375855360","doi":"10.2217/imt-2023-0062","title":"Treatment of Plaque Psoriasis with Deucravacitinib (Poetyk Pso-2 Study): A Plain Language Summary","year":2023,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research","funders":"Bristol-Myers Squibb","keywords":"Psoriasis; Plaque psoriasis; Medicine; Dermatology","authors":[{"name":"Bruce Strober","is_ca":false},{"name":"Diamant Thaçi","is_ca":false},{"name":"Howard Sofen","is_ca":false},{"name":"Leon Kircik","is_ca":false},{"name":"Kenneth B. Gordon","is_ca":false},{"name":"Peter Foley","is_ca":false},{"name":"Phoebe Rich","is_ca":false},{"name":"C. Paul","is_ca":false},{"name":"Jerry Bagel","is_ca":false},{"name":"Elizabeth Colston","is_ca":false},{"name":"John Throup","is_ca":false},{"name":"Sudeep Kundu","is_ca":false},{"name":"Chitra Sekaran","is_ca":false},{"name":"Misti Linaberry","is_ca":false},{"name":"Subhashis Banerjee","is_ca":false},{"name":"Kim Papp","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01778521998774822,"gpt":0.2671503374702288,"spread":0.2493651174824805,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006345713,0.00101588,0.003164515,0.001309885,0.0003793827,0.003743597,0.001181221,0.001930774,0.01148158],"category_scores_gemma":[0.009939693,0.0004940418,0.003791616,0.001772706,0.0004138231,0.001844521,0.0007859104,0.003344798,0.004661411],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001091731,"about_ca_system_score_gemma":0.002941785,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001636781,"about_ca_topic_score_gemma":0.002274981,"domain_scores_codex":[0.9971555,0.001038976,0.0008109511,0.0001948139,0.0006500503,0.0001495786],"domain_scores_gemma":[0.9900254,0.004599314,0.002243269,0.0001796043,0.002411645,0.000540778],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.007825227,0.0004045101,0.001693218,0.09394056,0.00259891,0.0003186367,0.0002053747,0.0004862245,0.0013467,0.00136197,0.4503952,0.4394236],"study_design_scores_gemma":[0.007619461,0.006431348,0.009846078,0.05572244,0.005776972,0.0006656674,0.0002594558,0.0002938708,0.0008387431,0.00178741,0.9106083,0.0001502701],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.003707163,0.8714415,0.002431691,0.06586492,0.01984846,0.002041238,0.01588544,0.0002894128,0.01849015],"genre_scores_gemma":[0.01552234,0.8157609,0.005064058,0.09637483,0.03381699,0.002939235,0.01576849,0.0002218879,0.01453128],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.01148158,"threshold_uncertainty_score":0.03840971,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3199359059","doi":"10.2217/imt-2021-0133","title":"Immunoregulatory T cell Epitope Peptides for the Treatment of Allergic Disease","year":2021,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"Regeneron Pharmaceuticals","keywords":"Epitope; Immunology; Disease; Medicine; Immunotherapy; Epitope mapping; Antibody; Immune system; Pathology","authors":[{"name":"Rashi Ramchandani","is_ca":true},{"name":"Lubnaa Hossenbaccus","is_ca":true},{"name":"Anne K. Ellis","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04693637287601039,"gpt":0.3326651217605675,"spread":0.2857287488845571,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004367551,0.0008006236,0.001205425,0.001915666,0.0001935076,0.000714607,0.0006226301,0.0008489677,0.005080278],"category_scores_gemma":[0.0005094527,0.0001468723,0.0007826179,0.001440847,0.0002646385,0.0006961842,0.0005385181,0.001566334,0.001804283],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003314502,"about_ca_system_score_gemma":0.0006457991,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006274795,"about_ca_topic_score_gemma":0.001008555,"domain_scores_codex":[0.9998339,0.00003714448,0.0000232077,0.00002430194,0.00006246693,0.00001887878],"domain_scores_gemma":[0.9998379,0.00008445806,0.00002713369,0.000005793775,0.00003176767,0.00001288175],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001109208,0.0001026766,0.0001032731,0.04344665,0.0002143124,0.0001578522,0.0000472042,0.0002935615,0.002384566,0.002080124,0.01974048,0.9313185],"study_design_scores_gemma":[0.00005865719,0.0001651487,0.0009489687,0.01066768,0.0004030481,0.001183933,0.00004864433,0.00008752232,0.0006003515,0.001652329,0.9841678,0.00001592051],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009700078,0.9991248,0.00005679814,0.00008004233,0.0001098951,0.000005872142,0.00001263503,0.000004744896,0.0005082485],"genre_scores_gemma":[0.0007239313,0.9985967,0.0001079576,0.0001082029,0.0000831886,0.00000728431,0.00002611557,0.000001096636,0.0003455439],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005080278,"threshold_uncertainty_score":0.01699525,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2908942081","doi":"10.2217/imt-2018-0167","title":"Immune Checkpoint Inhibitors and Non-Small-Cell Lung Cancer Management: 2018 Update","year":2019,"lang":"en","type":"editorial","venue":"Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Pembrolizumab; Atezolizumab; Nivolumab; Medicine; Lung cancer; Oncology; Internal medicine; Docetaxel; Avelumab; Ipilimumab; Cancer; Immunotherapy","authors":[{"name":"Omar Abdel‐Rahman","is_ca":true},{"name":"Don Morris","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.005902408804642505,"gpt":0.2602707838035951,"spread":0.2543683749989526,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004564513,0.00181955,0.002560754,0.002338967,0.001124205,0.003916559,0.001886284,0.006599987,0.003875439],"category_scores_gemma":[0.0144227,0.0006292951,0.001532367,0.00117182,0.001161344,0.002887446,0.001217747,0.01372575,0.003812478],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002174282,"about_ca_system_score_gemma":0.002410806,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001380802,"about_ca_topic_score_gemma":0.004705093,"domain_scores_codex":[0.9976059,0.0005450699,0.0004244596,0.000242099,0.001015306,0.0001672324],"domain_scores_gemma":[0.9893458,0.004895127,0.0009505489,0.0001326671,0.003681347,0.0009944296],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006540905,0.00001727646,0.0000651228,0.0005274537,0.00003380241,0.00008908976,0.000009857769,0.00003580052,0.00006071067,0.0004218042,0.9685972,0.03007644],"study_design_scores_gemma":[0.0001127688,0.00005887864,0.0004053198,0.001332253,0.0001482438,0.0004286717,0.00003470365,0.0001889929,0.0001071762,0.0008532949,0.9963065,0.00002313756],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.00008455106,0.06807377,0.0002732042,0.05826679,0.8712261,0.00001775247,0.00007564811,0.000055969,0.001926152],"genre_scores_gemma":[0.0007005686,0.04713677,0.0002572252,0.04198385,0.9046177,0.00002101882,0.00007172526,0.00002703259,0.005184126],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.006599987,"threshold_uncertainty_score":0.0241397,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3109227879","doi":"10.2217/imt-2020-0265","title":"Prognosticating Role of Serum Eosinophils on Immunotherapy Efficacy in Patients with Advanced Melanoma","year":2020,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"","keywords":"Eosinophilia; Medicine; Eosinophil; Melanoma; Immunotherapy; Internal medicine; Immunology; Retrospective cohort study; Gastroenterology; Oncology; Cancer research; Cancer; Asthma","authors":[{"name":"Adi Kartolo","is_ca":true},{"name":"Ryan Holstead","is_ca":true},{"name":"Wilma M. Hopman","is_ca":true},{"name":"Tara Baetz","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.006064718479399405,"gpt":0.2116574494295564,"spread":0.205592730950157,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004831849,0.0001920996,0.0002310921,0.0003517805,0.0001548592,0.0002750199,0.00010764,0.0002322169,0.0008283984],"category_scores_gemma":[0.001252148,0.0000860333,0.0001897398,0.000348516,0.0001405922,0.0002346688,0.0001811738,0.0002880731,0.0001325003],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008531965,"about_ca_system_score_gemma":0.0001070266,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002339423,"about_ca_topic_score_gemma":0.0003728159,"domain_scores_codex":[0.9998317,0.0000628852,0.00002077184,0.00003036047,0.00002146363,0.00003287104],"domain_scores_gemma":[0.9992142,0.00019246,0.0003831493,0.00003603966,0.00006169537,0.0001123884],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003903497,0.00001715648,0.9965209,0.000009158704,0.00001878108,0.00008952368,0.000009688218,0.00004981736,0.0005223175,0.0000093192,0.00003515011,0.002327763],"study_design_scores_gemma":[0.00001665347,0.0003403778,0.9976012,0.000008866837,0.00005129914,0.0008278814,0.00005514259,0.0003815214,0.0003458895,0.00003316761,0.0003346515,0.000003351651],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9986209,0.0009482129,0.0001156782,0.00002358898,0.00000618648,0.000004176046,0.00007262592,0.000002024452,0.0002066195],"genre_scores_gemma":[0.9996763,0.0001223861,0.00005623248,0.000007079445,0.00001131626,0.000001711336,0.00007162913,4.629207e-7,0.00005280926],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0008283984,"threshold_uncertainty_score":0.002771199,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4386591643","doi":"10.2217/imt-2023-0039","title":"Association Between Age and Efficacy of First-Line Immunotherapy-Based Combination Therapies for Mrcc: A Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Meta-analysis; Renal cell carcinoma; Sunitinib; Hazard ratio; Internal medicine; Kidney cancer; Immunotherapy; Oncology; Cancer; Confidence interval","authors":[{"name":"Takafumi Yanagisawa","is_ca":false},{"name":"Fahad Quhal","is_ca":false},{"name":"Tatsushi Kawada","is_ca":false},{"name":"Kensuke Bekku","is_ca":false},{"name":"Ekaterina Laukhtina","is_ca":false},{"name":"Paweł Rajwa","is_ca":false},{"name":"Markus von Deimling","is_ca":false},{"name":"Marcin Chłosta","is_ca":false},{"name":"Benjamin Pradère","is_ca":false},{"name":"Pierre I. Karakiewicz","is_ca":true},{"name":"Keiichiro Mori","is_ca":false},{"name":"Takahiro Kimura","is_ca":false},{"name":"Manuela Schmidinger","is_ca":false},{"name":"Shahrokh F. Shariat","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1570885263418611,"gpt":0.3821562660851957,"spread":0.2250677397433346,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008207904,0.002028595,0.01242063,0.00360578,0.0004523952,0.002223627,0.001153411,0.001606607,0.003256775],"category_scores_gemma":[0.01667023,0.0009145762,0.0344684,0.003842891,0.0003653153,0.001153813,0.0009093172,0.001694087,0.0002739893],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001613579,"about_ca_system_score_gemma":0.00198671,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004670034,"about_ca_topic_score_gemma":0.01002635,"domain_scores_codex":[0.9956529,0.002238667,0.001034813,0.0004806613,0.0004159856,0.0001768957],"domain_scores_gemma":[0.9906716,0.006756305,0.001506672,0.0002678902,0.0006471995,0.0001503261],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.004616326,0.00004516619,0.006825969,0.2339421,0.7323861,0.0001036799,0.00005404809,0.0008321127,0.0003138949,0.0001307304,0.0008373739,0.01991245],"study_design_scores_gemma":[0.0007014407,0.0002505545,0.004736033,0.01174676,0.9804543,0.00007984356,0.00002417842,0.0002643505,0.00009772139,0.0001640737,0.001465094,0.00001557879],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00542452,0.9932538,0.0003381782,0.0001473936,0.0001090173,0.0001255327,0.0003580229,0.00001296244,0.000230694],"genre_scores_gemma":[0.2378387,0.7569402,0.001955247,0.0008804451,0.0003542187,0.0006128873,0.0009895005,0.00002596726,0.0004028564],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01242063,"threshold_uncertainty_score":0.04340804,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4282831736","doi":"10.2217/imt-2021-0250","title":"No Association Between BMI and Immunotoxicity or Clinical Outcomes for Immune Checkpoint Inhibitors","year":2022,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Kingston Health Sciences Centre","funders":"","keywords":"Medicine; Internal medicine; Adverse effect; Oncology; Immune system; Immune checkpoint; Immunotherapy; Retrospective cohort study; Cancer; Population; Immunology","authors":[{"name":"Cynthia Yeung","is_ca":true},{"name":"Adi Kartolo","is_ca":true},{"name":"Ryan Holstead","is_ca":true},{"name":"Gordon Taylor Moffat","is_ca":true},{"name":"Lilian Hanna","is_ca":true},{"name":"Wilma M. Hopman","is_ca":true},{"name":"Tara Baetz","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03765313257344467,"gpt":0.3521172211629623,"spread":0.3144640885895177,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001659215,0.0001742616,0.0003696546,0.0004204918,0.0002274904,0.0004843225,0.0002382053,0.000316098,0.001941784],"category_scores_gemma":[0.006419268,0.000138659,0.0004912773,0.0005401562,0.0002697275,0.0003152213,0.000300817,0.000620315,0.0001918942],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000198497,"about_ca_system_score_gemma":0.0003564257,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003622891,"about_ca_topic_score_gemma":0.0006429578,"domain_scores_codex":[0.9993424,0.0002083086,0.00008775136,0.0001192111,0.000163868,0.00007833431],"domain_scores_gemma":[0.9911204,0.002943202,0.003994298,0.0004954849,0.0005934654,0.0008530812],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006360532,0.00001921546,0.9975418,0.00001377174,0.00009471223,0.00003702503,0.000007953759,0.0000331683,0.0002989651,0.00001240675,0.00003250555,0.001272481],"study_design_scores_gemma":[0.00002100219,0.0004481707,0.9985885,0.000007667559,0.0001036108,0.0003358609,0.0000254966,0.0001295323,0.000122822,0.00003417902,0.0001797053,0.000003403387],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978149,0.0009300961,0.000191537,0.00007041216,0.00001915452,0.000009488613,0.0002210886,0.000003703017,0.0007396043],"genre_scores_gemma":[0.9995553,0.00008998085,0.0000647792,0.00003450573,0.00001560705,0.000004949909,0.0001683077,0.000001945197,0.00006456167],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001941784,"threshold_uncertainty_score":0.008774877,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4384662972","doi":"10.2217/imt-2023-0012","title":"Mirikizumab for the Treatment of Moderate to Severe Ulcerative Colitis","year":2023,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University; University of Calgary","funders":"","keywords":"Ulcerative colitis; Tofacitinib; Medicine; Colitis; Drug; Inflammation; Internal medicine; Immunology; Pharmacology; Disease","authors":[{"name":"Jurij Hanžel","is_ca":false},{"name":"Christopher Ma","is_ca":true},{"name":"Vipul Jairath","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04020959227294852,"gpt":0.3431351967940178,"spread":0.3029256045210693,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003475227,0.0006619832,0.0009950267,0.00162144,0.0002174214,0.0006232386,0.0006956381,0.0007247675,0.003722013],"category_scores_gemma":[0.0004093934,0.000176441,0.0004812039,0.001166427,0.0002769507,0.0006455,0.0004627445,0.001736076,0.002304756],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003506668,"about_ca_system_score_gemma":0.00049639,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005952278,"about_ca_topic_score_gemma":0.001488659,"domain_scores_codex":[0.9998878,0.00001976805,0.00001611757,0.00001960554,0.000042933,0.00001376468],"domain_scores_gemma":[0.9998819,0.0000503854,0.00002270342,0.000003565873,0.00002573903,0.00001575072],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001310463,0.00006648313,0.00009691595,0.008725191,0.00009124647,0.0002160388,0.00002975324,0.0002053183,0.001236225,0.001360529,0.02784734,0.959994],"study_design_scores_gemma":[0.00007336975,0.000131746,0.0007359786,0.002915228,0.000161593,0.002086175,0.00002661187,0.00009019033,0.0004588377,0.001092166,0.9922131,0.00001499284],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001609326,0.9982734,0.00009142045,0.0001723572,0.0001951395,0.000005572154,0.00001535525,0.000008958602,0.001076804],"genre_scores_gemma":[0.001219983,0.9972625,0.0001600877,0.0002566256,0.0001606654,0.000008411027,0.00004328278,0.000002558134,0.0008859034],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003722013,"threshold_uncertainty_score":0.01245135,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4394873105","doi":"10.2217/imt-2023-0219","title":"Positioning risankizumab in the treatment algorithm of moderate-to-severe Crohn's disease","year":2024,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Crohn's disease; Internal medicine; Monoclonal antibody; Monoclonal; Disease; Immunology; Antibody","authors":[{"name":"Francesca Lusetti","is_ca":false},{"name":"Ferdinando D’Amico","is_ca":false},{"name":"Mariangela Allocca","is_ca":false},{"name":"Federica Furfaro","is_ca":false},{"name":"Alessandra Zilli","is_ca":false},{"name":"Gionata Fiorino","is_ca":false},{"name":"Tommaso Lorenzo Parigi","is_ca":false},{"name":"Simona Radice","is_ca":false},{"name":"Laurent Peyrin‐Biroulet","is_ca":true},{"name":"Silvio Danese","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01637599975543938,"gpt":0.3122671550094165,"spread":0.2958911552539771,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002102201,0.0007339543,0.002171377,0.004794227,0.0003343424,0.001477988,0.001123693,0.001393905,0.002173837],"category_scores_gemma":[0.003793218,0.0003560652,0.001472115,0.00370579,0.0005787765,0.001646453,0.0008778818,0.001061357,0.0006932862],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001886492,"about_ca_system_score_gemma":0.004453552,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003183136,"about_ca_topic_score_gemma":0.006104596,"domain_scores_codex":[0.9985948,0.0004892764,0.0004890884,0.0001278197,0.0002347034,0.00006422227],"domain_scores_gemma":[0.9983224,0.0008036067,0.0004445354,0.00002373402,0.0003578605,0.00004788331],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003337696,0.00003781414,0.0009238931,0.253664,0.0006850656,0.0001983123,0.0002797215,0.0005053576,0.0009539673,0.00374365,0.01763828,0.7210363],"study_design_scores_gemma":[0.0003906687,0.0003114484,0.004720531,0.4670858,0.005874854,0.001949856,0.0004581168,0.0004937188,0.0006537955,0.003540466,0.5144531,0.00006765409],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000246143,0.9978376,0.0001740963,0.0007062729,0.0001610272,0.00005231074,0.00004361653,0.000007342013,0.0007716233],"genre_scores_gemma":[0.004116567,0.9933364,0.001178031,0.0008189805,0.0001198341,0.00008538051,0.0000962645,0.000003066909,0.0002454169],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004794227,"threshold_uncertainty_score":0.01368749,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1979255880","doi":"10.2217/imt.10.44","title":"Emerging applications of lentiviral vectors in dendritic cell-based immunotherapy","year":2010,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"Canadian Institutes of Health Research","keywords":"Immunotherapy; Dendritic cell; Immunology; Viral vector; Immune system; Cancer immunotherapy; Antigen; Biology; Antigen-presenting cell; T cell; Autoimmunity; Cytotoxic T cell; Medicine; In vitro; Recombinant DNA","authors":[{"name":"Huiming Wang","is_ca":true},{"name":"Liang Zhang","is_ca":true},{"name":"Sam K. P. Kung","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01832265053708337,"gpt":0.3438783695124331,"spread":0.3255557189753497,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008208198,0.0008797609,0.001087382,0.001834733,0.0002537167,0.0009919612,0.0008194994,0.001131935,0.002072942],"category_scores_gemma":[0.0003916548,0.0003206353,0.0003986064,0.002056833,0.0005379269,0.001565075,0.0005953715,0.001842348,0.002395229],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008115871,"about_ca_system_score_gemma":0.0007248875,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006426751,"about_ca_topic_score_gemma":0.0007362391,"domain_scores_codex":[0.9998111,0.00002751298,0.00002318779,0.00002879296,0.00009192314,0.00001749606],"domain_scores_gemma":[0.9998174,0.00007255998,0.00002471247,0.000008544296,0.00005237056,0.00002454629],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000066542,0.0001163957,0.0001783479,0.00658932,0.00005350049,0.0003496382,0.00006255897,0.000517084,0.01540759,0.008390834,0.01210076,0.9561675],"study_design_scores_gemma":[0.0000322175,0.0001111485,0.0004731981,0.0009970025,0.00006226075,0.001694487,0.00004096451,0.0002384869,0.005842773,0.003319202,0.9871645,0.00002382817],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003327193,0.9964898,0.001084894,0.0002203381,0.0001951935,0.000009734129,0.00001631539,0.00002454831,0.001626426],"genre_scores_gemma":[0.001257623,0.9960776,0.001292331,0.0001920112,0.0001478576,0.00001219993,0.00003799805,0.000004016233,0.0009782774],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002072942,"threshold_uncertainty_score":0.006934643,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4383186917","doi":"10.2217/imt-2023-0069","title":"A Plain Language Summary on Ritlecitinib Treatment for Adults and Adolescents with Alopecia Areata","year":2023,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"Pfizer","keywords":"Alopecia areata; Medicine; Dermatology; Pediatrics","authors":[{"name":"Brett King","is_ca":false},{"name":"Xingqi Zhang","is_ca":false},{"name":"Walter Gubelin Harcha","is_ca":false},{"name":"Jacek C. Szepietowski","is_ca":false},{"name":"Jerry Shapiro","is_ca":false},{"name":"Charles Lynde","is_ca":true},{"name":"Natasha Atanaskova Mesinkovska","is_ca":false},{"name":"Samuel H. Zwillich","is_ca":false},{"name":"Lynne Napatalung","is_ca":false},{"name":"Dalia Wajsbrot","is_ca":false},{"name":"Rana Fayyad","is_ca":false},{"name":"Amy Freyman","is_ca":false},{"name":"Debanjali Mitra","is_ca":false},{"name":"Vivek S. Purohit","is_ca":false},{"name":"Rodney Sinclair","is_ca":false},{"name":"Robert Wołk","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01251077123518095,"gpt":0.2805351663317076,"spread":0.2680243950965266,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004925111,0.0006234135,0.001427025,0.0007468741,0.0004131489,0.001119858,0.0007646391,0.00186153,0.06271464],"category_scores_gemma":[0.00315342,0.0002188407,0.0008541991,0.0006006071,0.0001609406,0.001161502,0.0003841073,0.002051322,0.01981629],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007478818,"about_ca_system_score_gemma":0.0008268353,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002141586,"about_ca_topic_score_gemma":0.004163967,"domain_scores_codex":[0.9996501,0.0001023705,0.0001022725,0.00003227782,0.00007400469,0.00003903356],"domain_scores_gemma":[0.9981226,0.00070917,0.0003451965,0.00001919936,0.0005422336,0.0002616],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003492951,0.00008343908,0.0002892191,0.002354122,0.00002528181,0.0002402144,0.00003006676,0.00005156289,0.0003081666,0.000163834,0.9087676,0.08733714],"study_design_scores_gemma":[0.0003415336,0.0006908692,0.00359993,0.004045906,0.0000922672,0.001108878,0.00009518681,0.0000662978,0.0001551668,0.000253711,0.9895241,0.00002614913],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.007339736,0.4516825,0.001877821,0.2634339,0.06516072,0.002073211,0.02671517,0.001192174,0.1805247],"genre_scores_gemma":[0.02745866,0.3721315,0.003431217,0.3396577,0.07008611,0.00276695,0.02174204,0.00029719,0.1624287],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.06271464,"threshold_uncertainty_score":0.2098014,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3210787730","doi":"10.2217/imt-2021-0068","title":"Association Between PD-L1 Inhibitor, Tumor Site and Adverse Events of Potential Immune Etiology Within the US FDA Adverse Event Reporting System","year":2021,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Adverse effect; Adverse Event Reporting System; Common Terminology Criteria for Adverse Events; Internal medicine; Ipilimumab; Oncology; Cancer; Immunotherapy; Nivolumab; Etiology; MedDRA; Kidney cancer; Pharmacovigilance","authors":[{"name":"Omar Abdel‐Rahman","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01024507710060336,"gpt":0.2668065637972968,"spread":0.2565614866966934,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004008269,0.0001701626,0.0003373422,0.001676499,0.0002054503,0.0005473614,0.0002519349,0.0003176108,0.002628384],"category_scores_gemma":[0.01988111,0.0001058396,0.000724467,0.001951347,0.0002118169,0.000479787,0.0003920031,0.000544233,0.0001872017],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000419846,"about_ca_system_score_gemma":0.0005565927,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001909507,"about_ca_topic_score_gemma":0.00211023,"domain_scores_codex":[0.9952663,0.001527886,0.001316307,0.0005278708,0.001074899,0.0002866149],"domain_scores_gemma":[0.938675,0.01852849,0.03815835,0.001186917,0.002667079,0.0007840861],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001971428,0.00002145522,0.9960098,0.00004298894,0.0001162192,0.00004721871,0.00000917304,0.0001292528,0.0001667097,0.000021698,0.000176159,0.003062134],"study_design_scores_gemma":[0.00001923154,0.0001877983,0.996744,0.00003794255,0.00009608098,0.0008286142,0.00004159828,0.0008192754,0.0002936326,0.00003872933,0.000885709,0.000007322114],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.986747,0.004427633,0.001794266,0.0004978869,0.00003005825,0.00009826825,0.003940257,0.0000473356,0.002417193],"genre_scores_gemma":[0.9978986,0.0003422044,0.0005208807,0.0001025059,0.00003311213,0.00002916792,0.0009102712,0.000004372867,0.0001589869],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004008269,"threshold_uncertainty_score":0.02119797,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2111454565","doi":"10.2217/imt.10.40","title":"T-Cell-Directed Treatment Strategies for Type 1 Diabetes and the Confounding Role of Inflammation","year":2010,"lang":"en","type":"editorial","venue":"Immunotherapy","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases; National Institutes of Health","keywords":"Type 2 diabetes; Inflammation; Confounding; Medicine; Diabetes mellitus; Type 1 diabetes; Bioinformatics; Immunology; Internal medicine; Biology; Endocrinology","authors":[{"name":"Maria Koulmanda","is_ca":false},{"name":"Terry B. Strom","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.00426918085693779,"gpt":0.2497773023748755,"spread":0.2455081215179377,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002401826,0.00162858,0.001020418,0.001009291,0.0006665095,0.002137567,0.001337134,0.003558131,0.01345103],"category_scores_gemma":[0.003801106,0.0003685996,0.0009722933,0.0004726733,0.00120572,0.002072775,0.0005514052,0.006921705,0.004267151],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008421454,"about_ca_system_score_gemma":0.0006799761,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002639168,"about_ca_topic_score_gemma":0.0006650831,"domain_scores_codex":[0.9991415,0.0001753797,0.00009851381,0.0001118198,0.0003738936,0.00009900101],"domain_scores_gemma":[0.9971361,0.00141058,0.0001561544,0.00009535303,0.0008449692,0.0003568774],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003211549,0.00007087045,0.0001175836,0.001010099,0.0000438161,0.0003565667,0.00003387641,0.0001288365,0.0009523014,0.002460514,0.9238438,0.07066048],"study_design_scores_gemma":[0.0000850713,0.00009413364,0.0002419147,0.0002973848,0.00004271559,0.000514014,0.00002907042,0.0001400084,0.0004759952,0.001238873,0.9968292,0.00001155618],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.001116086,0.1370062,0.00104202,0.06099652,0.7889594,0.00007814559,0.000112062,0.0001723903,0.01051719],"genre_scores_gemma":[0.006377541,0.137355,0.000631684,0.03492967,0.7898508,0.00007982532,0.0001088526,0.00008194698,0.03058473],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.01345103,"threshold_uncertainty_score":0.04499823,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2097078544","doi":"10.2217/imt.12.17","title":"Distinct Roles of Dendritic and B Cells in the Activation of Naive CD4 <sup>+</sup> T Cells","year":2012,"lang":"en","type":"editorial","venue":"Immunotherapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Saskatchewan","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Cell biology; Chemistry; Molecular biology; Biology; Immunology","authors":[{"name":"Christopher D. Rudulier","is_ca":true},{"name":"David R. Kroeger","is_ca":true},{"name":"Peter A. Bretscher","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.007320964166931451,"gpt":0.2407633208539423,"spread":0.2334423566870109,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002667643,0.0009456064,0.0009722091,0.0009770637,0.000864857,0.00199896,0.001135983,0.002639873,0.005536795],"category_scores_gemma":[0.002272992,0.0004489817,0.0007966851,0.000369673,0.001348925,0.001370554,0.0005298258,0.004927568,0.001845323],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00112612,"about_ca_system_score_gemma":0.001051422,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003590529,"about_ca_topic_score_gemma":0.0007934281,"domain_scores_codex":[0.9990514,0.000129641,0.0001176122,0.0001520467,0.0004202755,0.00012896],"domain_scores_gemma":[0.9978651,0.0007043806,0.0001209677,0.00005186822,0.0007520203,0.0005055725],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001414744,0.0001381028,0.0007484804,0.002302194,0.0001002957,0.001372537,0.0001705264,0.0002125854,0.01119087,0.004110033,0.8584691,0.1197706],"study_design_scores_gemma":[0.0001436629,0.000249536,0.001830157,0.0004287349,0.0001013094,0.001168247,0.0001470617,0.0002807078,0.00523564,0.00188109,0.988506,0.00002785312],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.006670553,0.07393402,0.001627817,0.04686142,0.8608567,0.0001147736,0.0001772848,0.0001556662,0.009601763],"genre_scores_gemma":[0.02751233,0.08435871,0.0008700723,0.02147393,0.8257758,0.0001094431,0.0002041327,0.00009499962,0.03960062],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.005536795,"threshold_uncertainty_score":0.01852244,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3041847701","doi":"10.2217/imt-2020-0153","title":"How COVID-19 Affects Patients Receivingc anticytokine and JAK Inhibitors in Rheumatology and Dermatology","year":2020,"lang":"en","type":"letter","venue":"Immunotherapy","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St Joseph's Health Care; Western University","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Rheumatology; Medicine; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Dermatology; Internal medicine; Immunology; Virology","authors":[{"name":"Ting Yi Jessica Chang","is_ca":true},{"name":"Janet Pope","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01718533552473916,"gpt":0.280928578010123,"spread":0.2637432424853838,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009638407,0.0002522466,0.0004570157,0.0004065279,0.001949288,0.001073787,0.0003435777,0.01015211,0.003394792],"category_scores_gemma":[0.006959033,0.0001744661,0.0005289417,0.0003888121,0.0007200035,0.001114082,0.0004609213,0.005388147,0.001458206],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002162696,"about_ca_system_score_gemma":0.001296088,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008015784,"about_ca_topic_score_gemma":0.01093942,"domain_scores_codex":[0.9991593,0.0003266953,0.0001037477,0.0000840717,0.0001866625,0.0001395076],"domain_scores_gemma":[0.9983534,0.0008769549,0.00009744807,0.00004312997,0.0003266031,0.0003024845],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003767541,0.0003416806,0.03319776,0.0001819175,0.00006096418,0.04175555,0.0008371355,0.0002121857,0.001560919,0.005111727,0.8446075,0.07175597],"study_design_scores_gemma":[0.0005677674,0.0006908348,0.04293203,0.001234796,0.0001763774,0.1412219,0.00335993,0.002178165,0.001177042,0.02410142,0.7822085,0.0001513061],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"editorial","genre_scores_codex":[0.008857315,0.003830267,0.0001249629,0.968567,0.008942014,0.00001769924,0.00008147211,0.0000224196,0.009556741],"genre_scores_gemma":[0.113996,0.005034138,0.0005056536,0.8387856,0.02783507,0.00003702277,0.00007833385,0.00001714738,0.0137111],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.01015211,"threshold_uncertainty_score":0.01593822,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2792760898","doi":"10.2217/imt-2017-0162","title":"CD19-specific Chimeric Antigen Receptor-Modified (CAR)-T cell Therapy for the Treatment of Chronic Lymphocytic Leukemia in the Ibrutinib Era","year":2018,"lang":"en","type":"editorial","venue":"Immunotherapy","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Chronic lymphocytic leukemia; Ibrutinib; Medicine; Chimeric antigen receptor; Leukemia; Oncology; Cancer; Immunology; Internal medicine; Immunotherapy","authors":[{"name":"Kevin A. Hay","is_ca":true},{"name":"Cameron J. Turtle","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02654790113269132,"gpt":0.3216215715794757,"spread":0.2950736704467843,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004162932,0.002292809,0.002560224,0.001538887,0.001502738,0.003519458,0.002895847,0.01066234,0.006036669],"category_scores_gemma":[0.01003488,0.000702402,0.001935435,0.0007158605,0.001312334,0.003075279,0.0008471737,0.01556545,0.00428877],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002298962,"about_ca_system_score_gemma":0.001840239,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001239493,"about_ca_topic_score_gemma":0.003055936,"domain_scores_codex":[0.9980131,0.0004317697,0.0003054688,0.0002147396,0.0008714313,0.0001633078],"domain_scores_gemma":[0.9934844,0.003058226,0.0004364886,0.000126399,0.001949861,0.0009444917],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001473212,0.00002848713,0.00002709766,0.0004456398,0.00003573587,0.0001620796,0.00001074575,0.00005115316,0.0001458099,0.0005408418,0.9823202,0.01608489],"study_design_scores_gemma":[0.000266275,0.0001211847,0.0002777661,0.0004454794,0.0001175919,0.0004425033,0.00002317355,0.0002500747,0.0002560117,0.0009853331,0.9967913,0.00002320503],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.00007993652,0.02074308,0.0001906444,0.03400834,0.9436322,0.00002027805,0.00004606256,0.00005750576,0.001222074],"genre_scores_gemma":[0.0008255978,0.01839096,0.0001540811,0.02664624,0.9464931,0.00002126353,0.0000368899,0.00002190399,0.007409757],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.01066234,"threshold_uncertainty_score":0.02201599,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4409810942","doi":"10.1080/1750743x.2025.2491295","title":"Rozanolixizumab for Myasthenia Gravis: a breakthrough treatment and future prospects","year":2025,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Myasthenia gravis; Medicine; Intensive care medicine; Immunology","authors":[{"name":"Alexandria Matic","is_ca":true},{"name":"Vera Bril","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02313870609892407,"gpt":0.3524213016010471,"spread":0.329282595502123,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005839922,0.0006386087,0.001319701,0.001756439,0.0002011681,0.0007953949,0.000638205,0.0009616869,0.003395161],"category_scores_gemma":[0.000581426,0.0002047213,0.0007596348,0.001550321,0.0003242503,0.00110847,0.0004392779,0.001632881,0.001126922],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004960045,"about_ca_system_score_gemma":0.0009132591,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008853164,"about_ca_topic_score_gemma":0.00188548,"domain_scores_codex":[0.999851,0.00003246127,0.00002547397,0.00002666394,0.00004910549,0.00001525574],"domain_scores_gemma":[0.9997627,0.0001265163,0.00003688451,0.00000611112,0.00004782972,0.00002007066],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000142356,0.00007755855,0.0001193537,0.02867794,0.0001491442,0.00018825,0.00006515632,0.0002733547,0.001504867,0.00257337,0.02383081,0.9423978],"study_design_scores_gemma":[0.00009376874,0.0002189402,0.0010191,0.01055086,0.0004156521,0.001772712,0.00007761842,0.0001413043,0.0003369418,0.002151991,0.9831982,0.00002295353],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008075677,0.9993497,0.00003710165,0.0001757308,0.00008041172,0.000002140024,0.000006473817,0.000003367989,0.0002644266],"genre_scores_gemma":[0.0004299535,0.9989549,0.00009732145,0.0001906356,0.00008866941,0.000003961325,0.00001338098,8.892864e-7,0.0002203626],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003395161,"threshold_uncertainty_score":0.01135796,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4322617905","doi":"10.2217/imt-2022-0210","title":"Antithymocyte Globulin for Aplastic Anemia Secondary to Pembrolizumab: A Case Report and Review of Literature","year":2023,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"","keywords":"Aplastic anemia; Medicine; Pembrolizumab; Anemia; Immunology; Globulin; Immunotherapy; Internal medicine; Immune system; Gastroenterology; Bone marrow","authors":[{"name":"Cynthia Yeung","is_ca":true},{"name":"Nicole Relke","is_ca":true},{"name":"David Good","is_ca":true},{"name":"Natasha Satkunam","is_ca":true},{"name":"Mihaela Mates","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03739182895557941,"gpt":0.3728252956821091,"spread":0.3354334667265297,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003437763,0.0007733827,0.001471811,0.00425726,0.0004224322,0.0008765758,0.0007785466,0.001170374,0.002784526],"category_scores_gemma":[0.0009528052,0.0002685358,0.0007969703,0.003762094,0.0004262993,0.001196308,0.0004610544,0.0009666719,0.0008998377],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000424085,"about_ca_system_score_gemma":0.001053885,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00123209,"about_ca_topic_score_gemma":0.002189806,"domain_scores_codex":[0.9997619,0.00003815802,0.00007449719,0.00003938371,0.00006633681,0.00001970424],"domain_scores_gemma":[0.9995073,0.0002770545,0.0001160632,0.00001374345,0.00005998595,0.00002595605],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"case_report","study_design_scores_codex":[0.0001272485,0.0001484509,0.00156581,0.0900104,0.0007201897,0.03450606,0.0003619981,0.0004333021,0.003012106,0.001912225,0.04306726,0.824135],"study_design_scores_gemma":[0.00005439008,0.0002108941,0.006205565,0.0463696,0.002342959,0.2576166,0.0006070873,0.000263256,0.001209154,0.002591414,0.6824395,0.00008961707],"study_design_candidate":"case_report","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004334797,0.998315,0.0000922294,0.0002392235,0.000144662,0.000005822177,0.00001893619,0.000005847401,0.0007448284],"genre_scores_gemma":[0.002625295,0.9963728,0.000190764,0.0003076047,0.0002155262,0.000005039246,0.00003153403,0.00000173288,0.0002498303],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00425726,"threshold_uncertainty_score":0.009315133,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2513976653","doi":"10.2217/imt-2016-0070","title":"Controlling Inflammation: A Superior Way to Control TB","year":2016,"lang":"en","type":"editorial","venue":"Immunotherapy","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Tuberculosis; Medicine; Human immunodeficiency virus (HIV); MEDLINE; Mycobacterium tuberculosis; Family medicine; Library science; Internal medicine; Pathology; Computer science; Biology","authors":[{"name":"Nancy Gupta","is_ca":true},{"name":"Babita Agrawal","is_ca":true},{"name":"Rakesh Kumar","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01192464604605101,"gpt":0.3318239860897753,"spread":0.3198993400437243,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01760275,0.006423913,0.008101482,0.005599866,0.003797675,0.01267061,0.006231406,0.03525906,0.009847522],"category_scores_gemma":[0.0523585,0.002561172,0.004308737,0.002789166,0.005055796,0.009722529,0.003865502,0.04585841,0.0107583],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005535112,"about_ca_system_score_gemma":0.006545293,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002448746,"about_ca_topic_score_gemma":0.007309339,"domain_scores_codex":[0.9847074,0.003889906,0.002760638,0.001357974,0.006491427,0.0007926147],"domain_scores_gemma":[0.9532663,0.02303332,0.003809115,0.00141656,0.01322803,0.005246677],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006380433,0.00002070157,0.00003122022,0.0006345069,0.00007525584,0.00008837799,0.00001510702,0.00002770055,0.00004158195,0.0005215983,0.990715,0.007765117],"study_design_scores_gemma":[0.0002028559,0.00006376864,0.0003031793,0.00135175,0.0002802683,0.0002998725,0.00004935584,0.0001935879,0.0001099617,0.002882035,0.9942203,0.0000431502],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.00001384425,0.01608967,0.00009818016,0.04877023,0.9343961,0.00001315845,0.00003093978,0.000028061,0.0005599646],"genre_scores_gemma":[0.000147496,0.007578803,0.00008035045,0.02462103,0.9648173,0.00001412849,0.00001350371,0.00001618118,0.002711251],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.03525906,"threshold_uncertainty_score":0.0930934,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2804640215","doi":"10.2217/imt-2018-0003","title":"Ragweed Sublingual Tablet Immunotherapy: Part II – Practical Considerations and Pertinent Issues","year":2018,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Ragweed; Sublingual immunotherapy; Medicine; Slit; Allergy; Clinical trial; Dermatology; Immunotherapy; Allergic asthma; Asthma; Allergen immunotherapy; Intensive care medicine; Allergen; Immunology; Internal medicine; Immune system","authors":[{"name":"Oliver Pfaar","is_ca":false},{"name":"Peter S. Creticos","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08254104935116863,"gpt":0.3923671133085607,"spread":0.3098260639573921,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008886729,0.0005507505,0.001265722,0.002170893,0.0002888192,0.001441159,0.000678773,0.001301193,0.005410017],"category_scores_gemma":[0.002089813,0.0002837803,0.0008049437,0.002084691,0.0005219347,0.002056828,0.0006344912,0.001530781,0.001384335],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004808845,"about_ca_system_score_gemma":0.001548682,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001079798,"about_ca_topic_score_gemma":0.00212069,"domain_scores_codex":[0.9995385,0.0001151225,0.0001141235,0.00005719986,0.0001436998,0.00003134814],"domain_scores_gemma":[0.9988808,0.0006649976,0.0001721957,0.00002769039,0.0002168126,0.00003750256],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008165728,0.00007206057,0.0001988772,0.0847007,0.0001435817,0.0004892783,0.0002798759,0.0002419155,0.002127019,0.005193607,0.06611467,0.8403568],"study_design_scores_gemma":[0.00001452725,0.00007404825,0.0007423411,0.01747469,0.0001384473,0.002153139,0.0001439887,0.00005672005,0.0002753951,0.001882884,0.977029,0.00001482784],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007975551,0.9984418,0.00004737563,0.0006015576,0.0002858853,0.000005588971,0.00001276563,0.000002239172,0.0005230911],"genre_scores_gemma":[0.000709913,0.9976112,0.0001395331,0.0005947198,0.0004343779,0.000009139358,0.00002122437,0.000001645254,0.0004782226],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005410017,"threshold_uncertainty_score":0.01809829,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4407081442","doi":"10.1080/1750743x.2025.2455922","title":"Exploring the role of immunotherapy in the management of follicular cell-derived thyroid cancer","year":2025,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Cancer immunotherapy; Immunotherapy; Thyroid cancer; Follicular phase; Medicine; Follicular cell; Cancer research; Follicular thyroid cancer; Thyroid; Oncology; Immunology; Cancer; Internal medicine; Papillary thyroid cancer","authors":[{"name":"Omar Abdel‐Rahman","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04647064221397133,"gpt":0.326399704560524,"spread":0.2799290623465527,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005236948,0.0005059263,0.001111546,0.001664701,0.0001984635,0.0007895438,0.0005816167,0.0008087446,0.002829052],"category_scores_gemma":[0.0007443275,0.0001668043,0.0006809913,0.001335622,0.0002367849,0.0007985336,0.0004740974,0.001335635,0.0008289401],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005095884,"about_ca_system_score_gemma":0.001007045,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001008754,"about_ca_topic_score_gemma":0.002092455,"domain_scores_codex":[0.9998341,0.0000415032,0.00002986135,0.00002521824,0.00005310786,0.0000161494],"domain_scores_gemma":[0.999737,0.0001613452,0.00003282348,0.000005523174,0.00005071026,0.00001265401],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001045822,0.00005977231,0.0001447375,0.04605304,0.0002102515,0.0001723095,0.00006886616,0.0003953997,0.001660962,0.002500637,0.01558242,0.9330469],"study_design_scores_gemma":[0.00004325465,0.0001935013,0.00110956,0.01750547,0.000492968,0.001545241,0.0000842669,0.0001382324,0.0005915986,0.002131103,0.9761439,0.00002096793],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008366462,0.9992531,0.00005143777,0.0001231126,0.00008067962,0.000003562251,0.0000100182,0.000002442138,0.000391959],"genre_scores_gemma":[0.0005566964,0.9989484,0.00009279149,0.0001346145,0.00006489867,0.000004669185,0.00001832974,6.856418e-7,0.000178965],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002829052,"threshold_uncertainty_score":0.009464085,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4403247213","doi":"10.1080/1750743x.2024.2408216","title":"Breaking the mold: nontraditional approaches to allergen immunotherapy for environmental allergens","year":2024,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University; University of Toronto; Kingston Health Sciences Centre; University of Ottawa","funders":"","keywords":"Medicine; Immunotherapy; Allergen immunotherapy; Omalizumab; Desensitization (medicine); Allergen; Immunology; Dosing; Allergy; Intensive care medicine; Immunoglobulin E; Immune system; Internal medicine; Antibody","authors":[{"name":"Rashi Ramchandani","is_ca":true},{"name":"Rachel Lucyshyn","is_ca":true},{"name":"Sophia Linton","is_ca":true},{"name":"Anne K. Ellis","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1560110096589077,"gpt":0.3240526827005774,"spread":0.1680416730416697,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000608552,0.0008181393,0.001277723,0.003105744,0.0002896299,0.001074175,0.000657399,0.0009649258,0.004682047],"category_scores_gemma":[0.0007495668,0.0002398224,0.001106519,0.002337568,0.000483371,0.001562547,0.0006960247,0.00197148,0.001467264],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005590226,"about_ca_system_score_gemma":0.001197071,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001037672,"about_ca_topic_score_gemma":0.002149807,"domain_scores_codex":[0.9996821,0.00006855639,0.00004384254,0.00004900719,0.0001303654,0.00002614024],"domain_scores_gemma":[0.9996675,0.0002099983,0.0000387884,0.00001319336,0.00005584416,0.00001471161],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007141897,0.000121317,0.0001278847,0.06260954,0.0002074289,0.0001670406,0.0001272552,0.0003180649,0.002362277,0.006517875,0.01416683,0.9132031],"study_design_scores_gemma":[0.0000260576,0.0001363221,0.0008755372,0.01346039,0.0002540236,0.001063283,0.0000977058,0.00009289002,0.000633318,0.003226103,0.9801155,0.00001876302],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001185923,0.9985762,0.0001336631,0.0001596543,0.0001217615,0.00000703547,0.00001152695,0.000005327183,0.0008662889],"genre_scores_gemma":[0.0007755348,0.9982141,0.0002687775,0.0001991335,0.0000734916,0.000008489682,0.00002296352,0.000001724754,0.0004358652],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004682047,"threshold_uncertainty_score":0.01566297,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4383872841","doi":"10.2217/imt-2022-0257","title":"An Assessment of Extended Pembrolizumab Dosing in Advanced Non-Small-Cell Lung Cancer in the Covid-19 Pandemic","year":2023,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University; Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Pembrolizumab; Medicine; Dosing; Lung cancer; Adverse effect; Internal medicine; Cancer; Retrospective cohort study; Toxicity; Gastroenterology; Immunotherapy","authors":[{"name":"Gordon Taylor Moffat","is_ca":true},{"name":"Lilian Hanna","is_ca":true},{"name":"Wilma M. Hopman","is_ca":true},{"name":"Andrea S. Fung","is_ca":true},{"name":"Pierre-Olivier Gaudreau","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03164804547800199,"gpt":0.4021801051586452,"spread":0.3705320596806432,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004455603,0.0001676574,0.0003824293,0.0002956773,0.0001749846,0.0005399514,0.0003573803,0.0003417273,0.0008592473],"category_scores_gemma":[0.007134546,0.0001064842,0.0003154908,0.0003924108,0.0001965886,0.0006389563,0.0004641743,0.0005136058,0.0001110731],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007027807,"about_ca_system_score_gemma":0.0004960191,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006305532,"about_ca_topic_score_gemma":0.0007053212,"domain_scores_codex":[0.9984661,0.0006837505,0.0001905839,0.0002205922,0.0003434113,0.00009560651],"domain_scores_gemma":[0.9951675,0.001366423,0.002328857,0.0002689177,0.0004740036,0.0003942955],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01217801,0.0006947236,0.9241141,0.0001343108,0.0002319153,0.00008507817,0.0001494703,0.001156176,0.001754337,0.0000973326,0.0004537582,0.05895073],"study_design_scores_gemma":[0.0004732514,0.01707953,0.9760655,0.00005758219,0.0001178673,0.0004162208,0.0001580601,0.001752845,0.0009476354,0.00008312374,0.002835368,0.00001311406],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970048,0.001105115,0.0003242499,0.0001252158,0.00001204028,0.00007224147,0.0003451355,0.000005700697,0.001005519],"genre_scores_gemma":[0.9989995,0.0001736245,0.0002951422,0.0001063366,0.00001468437,0.00003237478,0.0003006555,0.000001763344,0.00007602276],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004455603,"threshold_uncertainty_score":0.02356374,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4405200272","doi":"10.1080/1750743x.2024.2436838","title":"Musculoskeletal immune-related adverse events of PD-(L)1 inhibitors in melanoma: a systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta; Research Canada; Dalhousie University","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health; American Academy of Allergy Asthma and Immunology","keywords":"Adverse effect; Medicine; Immune system; Melanoma; Pembrolizumab; Incidence (geometry); Meta-analysis; Oncology; Ipilimumab; Internal medicine; Immunotherapy; Immunology; Cancer research","authors":[{"name":"Janet Roberts","is_ca":true},{"name":"Sara Barmettler","is_ca":false},{"name":"Jenna Murray","is_ca":false},{"name":"Jennifer E. Melvin","is_ca":true},{"name":"Carrie Ye","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03227925669359021,"gpt":0.3540401153066937,"spread":0.3217608586131034,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009009881,0.002197735,0.01334025,0.004804581,0.0005189832,0.002479802,0.001583328,0.001900536,0.003582186],"category_scores_gemma":[0.02259679,0.001192848,0.03423636,0.005634282,0.0004951356,0.001119585,0.001160755,0.001648956,0.000257563],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002111048,"about_ca_system_score_gemma":0.003048574,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006169708,"about_ca_topic_score_gemma":0.01212593,"domain_scores_codex":[0.9936026,0.002990877,0.001745887,0.0006848295,0.0007443026,0.0002314746],"domain_scores_gemma":[0.9852399,0.01064762,0.002548879,0.0003258904,0.001068638,0.0001690941],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.002019003,0.00003054097,0.00362472,0.5019131,0.4751333,0.0001356696,0.00005568959,0.0006691752,0.0001941814,0.0001232817,0.0009330993,0.01516827],"study_design_scores_gemma":[0.000638445,0.0002069332,0.004430296,0.03625838,0.9558287,0.0001401994,0.00003291924,0.0002132001,0.000108148,0.0001829134,0.001935956,0.00002393793],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003625076,0.9947782,0.000304565,0.0001592768,0.0000998102,0.0001783417,0.0005918532,0.0000154617,0.0002474174],"genre_scores_gemma":[0.1264491,0.8692791,0.001312283,0.0007957293,0.0002348359,0.0007816009,0.0008218121,0.00002075767,0.0003046879],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01334025,"threshold_uncertainty_score":0.04764938,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4405111359","doi":"10.1080/1750743x.2024.2436346","title":"Concurrent immunotherapy and radiation in cisplatin-ineligible patients with HNSCC: a systematic review &amp; meta-analysis","year":2024,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Juravinski Cancer Centre; McMaster University","funders":"","keywords":"Medicine; Radiosensitizer; Oncology; Cisplatin; Head and neck squamous-cell carcinoma; Immunotherapy; Meta-analysis; Internal medicine; Radiation therapy; Standard of care; Head and neck cancer; Chemotherapy; Cancer","authors":[{"name":"Sze Wah Samuel Chan","is_ca":true},{"name":"Zainab Al Maqrashi","is_ca":true},{"name":"Jack Young","is_ca":true},{"name":"Do-Hoon Kim","is_ca":true},{"name":"Gregory R. Pond","is_ca":true},{"name":"Brandon M. Meyers","is_ca":true},{"name":"Adi Kartolo","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07829244723347409,"gpt":0.3949451119656623,"spread":0.3166526647321882,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0115876,0.002217151,0.01525932,0.004304633,0.0005110285,0.002873606,0.001825571,0.002045366,0.003425714],"category_scores_gemma":[0.02742564,0.001230902,0.02993161,0.006014493,0.0007242113,0.001436714,0.001272059,0.001599765,0.0002838057],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002533807,"about_ca_system_score_gemma":0.002779759,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007230363,"about_ca_topic_score_gemma":0.01562404,"domain_scores_codex":[0.992374,0.004102355,0.001842498,0.0007124733,0.0007322007,0.000236439],"domain_scores_gemma":[0.9843337,0.0112745,0.002925394,0.0004206378,0.000855896,0.0001898534],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.002256351,0.00002845904,0.002744725,0.3638902,0.6212152,0.00009973144,0.00006014756,0.0005068779,0.0001668115,0.0001179596,0.0005941063,0.008319483],"study_design_scores_gemma":[0.0007716833,0.0001911629,0.002494552,0.02084076,0.9739042,0.00007386791,0.00002958674,0.0001766751,0.00008683089,0.0001524758,0.001262523,0.00001559517],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004551325,0.9939745,0.000406819,0.0001523006,0.0001106208,0.0002508158,0.0003291165,0.00001891841,0.0002055009],"genre_scores_gemma":[0.2245746,0.7693071,0.002243728,0.0009870173,0.0002525912,0.00142777,0.0006926827,0.00003350312,0.0004808962],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01525932,"threshold_uncertainty_score":0.06128186,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4391882558","doi":"10.2217/imt-2023-0293","title":"Upadacitinib for the Treatment of Moderate-to-Severe Crohn’s Disease","year":2024,"lang":"en","type":"review","venue":"Immunotherapy","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University; University of Calgary","funders":"","keywords":"Medicine; Rheumatoid arthritis; Crohn's disease; Internal medicine; Janus kinase; Disease; Oncology; Malignancy; Cytokine","authors":[{"name":"Jurij Hanžel","is_ca":false},{"name":"Christopher Ma","is_ca":true},{"name":"Vipul Jairath","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02976364088780458,"gpt":0.3346496295131636,"spread":0.304885988625359,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003074032,0.000571087,0.001016978,0.001448149,0.0002092644,0.000707316,0.0006676472,0.0006730318,0.004640603],"category_scores_gemma":[0.0004001035,0.0001464701,0.0004739973,0.001113332,0.0002031961,0.0006202597,0.0004771372,0.001560784,0.002563965],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003741084,"about_ca_system_score_gemma":0.0005104868,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000607093,"about_ca_topic_score_gemma":0.001563074,"domain_scores_codex":[0.9998897,0.00001879416,0.00001500387,0.00001738777,0.00004353903,0.00001548969],"domain_scores_gemma":[0.9998965,0.00004176317,0.00001916729,0.000002841073,0.00002508763,0.0000146777],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001185979,0.00004790839,0.00008535512,0.009621139,0.00009667714,0.0001758547,0.00002865721,0.0002777045,0.0008715689,0.001548865,0.04041302,0.9467146],"study_design_scores_gemma":[0.00005617775,0.0000956544,0.0005621214,0.003150346,0.0001458977,0.001365952,0.00002643755,0.000109324,0.0003056399,0.001049188,0.9931197,0.00001355293],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001848567,0.9978896,0.00007937339,0.0001997758,0.0002295092,0.00000560617,0.00002829983,0.00001020198,0.001372779],"genre_scores_gemma":[0.001274155,0.9970527,0.000120841,0.0002406757,0.0001520522,0.000007748434,0.00007050567,0.000002552634,0.001078908],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004640603,"threshold_uncertainty_score":0.01552439,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4411260891","doi":"10.1080/1750743x.2025.2518913","title":"Time toxicity of nivolumab in metastatic head and neck squamous cell carcinoma patients: a single-institution experience","year":2025,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Hamilton Health Sciences; Population Health Research Institute; McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Nivolumab; Medicine; Head and neck; Toxicity; Basal cell; Oncology; Head and neck squamous-cell carcinoma; Radiation therapy; Internal medicine; Carcinoma; Head and neck cancer; Surgery; Cancer; Immunotherapy","authors":[{"name":"Michelle Bradbury","is_ca":true},{"name":"Adam Gabara","is_ca":true},{"name":"Gregory R. Pond","is_ca":true},{"name":"Brandon M. Meyers","is_ca":true},{"name":"Adi Kartolo","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01306248268983103,"gpt":0.2701643034079915,"spread":0.2571018207181605,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000607923,0.0001905043,0.0002821745,0.0004019446,0.0007227547,0.0007478775,0.0002833977,0.0002188745,0.0008294374],"category_scores_gemma":[0.002147939,0.0001585623,0.0002673016,0.0007707672,0.0004020825,0.0002685154,0.0006020651,0.0003149852,0.0001577437],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002925147,"about_ca_system_score_gemma":0.002158639,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0330644,"about_ca_topic_score_gemma":0.08985957,"domain_scores_codex":[0.9995504,0.0001038884,0.00006640544,0.00006352898,0.0001172638,0.00009849793],"domain_scores_gemma":[0.9985452,0.0002352587,0.0005755449,0.00006082059,0.0002532797,0.0003299172],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002220269,0.0001322654,0.9797188,0.0000611638,0.00004211154,0.0021918,0.001228263,0.0001706726,0.0007827097,0.0000240176,0.0003332225,0.01509301],"study_design_scores_gemma":[0.00004698044,0.001365455,0.9796908,0.00007723996,0.000099645,0.01060286,0.003746904,0.0004666747,0.001082022,0.0000530492,0.002742988,0.00002528929],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9989016,0.0003533428,0.00009189805,0.0000523888,0.000003050505,0.00003017245,0.00008955281,0.000003700896,0.0004741267],"genre_scores_gemma":[0.9992206,0.0003222258,0.000126602,0.00005675513,0.000007688556,0.00001014677,0.0001041624,0.000003444646,0.0001482841],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0330644,"threshold_uncertainty_score":0.06574386,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2069156224","doi":"10.2217/imt.12.27","title":"Research Highlights: Highlights from the Latest Articles in Immunotherapy","year":2012,"lang":"en","type":"letter","venue":"Immunotherapy","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Lawson Health Research Institute; Western University","funders":"","keywords":"Flora (microbiology); Immunology; Immune system; Autoimmunity; Disease; Gut flora; Biology; Nod; Microbiology; Medicine; Diabetes mellitus; Bacteria; Internal medicine; Genetics","authors":[{"name":"Kelly L. Summers","is_ca":true},{"name":"Bhagirath Singh","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03316066186204686,"gpt":0.3149871282129649,"spread":0.2818264663509181,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034468,0.001986979,0.00267255,0.001044069,0.002491598,0.005959168,0.002231621,0.01993548,0.008149319],"category_scores_gemma":[0.01224823,0.0006777062,0.001625267,0.001186299,0.002650259,0.003785335,0.001529448,0.03041598,0.005943314],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003498724,"about_ca_system_score_gemma":0.00205652,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001076655,"about_ca_topic_score_gemma":0.002770536,"domain_scores_codex":[0.9970927,0.0006809184,0.0003304467,0.0004196365,0.001080988,0.0003952938],"domain_scores_gemma":[0.9935562,0.002929365,0.000479797,0.0002033183,0.001552507,0.00127875],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001266006,0.00004362226,0.0001756294,0.0001729326,0.00002703888,0.001179115,0.00002654538,0.00006716709,0.0002456874,0.001192287,0.9765954,0.02014797],"study_design_scores_gemma":[0.0001849999,0.00008542963,0.0007700337,0.0002846001,0.000065345,0.001663728,0.0001319464,0.0002256759,0.0002879126,0.00419989,0.9920622,0.00003833569],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"editorial","genre_scores_codex":[0.0004408667,0.03329805,0.0003367564,0.7591549,0.2013024,0.00002962014,0.0001026185,0.00006950761,0.005265309],"genre_scores_gemma":[0.002929121,0.0167762,0.0004182116,0.3264346,0.6449057,0.00004205775,0.00006874431,0.00004245178,0.008382866],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.01993548,"threshold_uncertainty_score":0.02726221,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4407377433","doi":"10.1080/1750743x.2025.2457931","title":"Benralizumab in severe eosinophilic asthma by biologic use and key clinical subgroups: real-world XALOC-1 programme: a plain language summary of publication","year":2025,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"AstraZeneca (Canada)","funders":"McGill University; McMaster University; AstraZeneca","keywords":"Benralizumab; Asthma; Medicine; Eosinophilic; Internal medicine; Pathology; Eosinophil; Mepolizumab","authors":[{"name":"David J. Jackson","is_ca":false},{"name":"Girolamo Pelaia","is_ca":false},{"name":"Benjamin Emmanuel","is_ca":false},{"name":"Trung N. Tran","is_ca":false},{"name":"David Cohen","is_ca":false},{"name":"Vivian H. Shih","is_ca":false},{"name":"Anat Shavit","is_ca":false},{"name":"Douglas Arbetter","is_ca":false},{"name":"Rohit Katial","is_ca":false},{"name":"Adrian Rabe","is_ca":false},{"name":"Esther García Gil","is_ca":false},{"name":"Marisa Pardal","is_ca":false},{"name":"Javier Nuevo","is_ca":false},{"name":"Michael Watt","is_ca":false},{"name":"Silvia Boarino","is_ca":false},{"name":"Sheena Kayaniyil","is_ca":true},{"name":"Alicia Padilla‐Galo","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0220841725104322,"gpt":0.3304853682888036,"spread":0.3084011957783714,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02589005,0.001224339,0.00346372,0.002205035,0.0004737245,0.004996343,0.001281254,0.002717679,0.01504824],"category_scores_gemma":[0.07286982,0.0008024671,0.004754178,0.004836891,0.0005430352,0.00194741,0.001658067,0.002997353,0.003260839],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002388722,"about_ca_system_score_gemma":0.006366041,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001449746,"about_ca_topic_score_gemma":0.001587651,"domain_scores_codex":[0.9778994,0.01208964,0.005117629,0.001130038,0.002998343,0.0007649378],"domain_scores_gemma":[0.90941,0.0429156,0.02673524,0.00251918,0.01389989,0.004520058],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.04614956,0.0006583709,0.01104662,0.1599701,0.01147169,0.0002708643,0.0004341775,0.001059006,0.0009176849,0.001773757,0.4663381,0.29991],"study_design_scores_gemma":[0.05501886,0.01267799,0.08594324,0.1905937,0.02918873,0.0008526538,0.0006691736,0.0009129673,0.00149199,0.003200867,0.6189403,0.0005095418],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.02111139,0.6958033,0.004569758,0.1271679,0.04396548,0.0131547,0.07191423,0.0005308717,0.02178228],"genre_scores_gemma":[0.1361351,0.6014963,0.01787999,0.06007491,0.06948677,0.03875357,0.06274851,0.0007163527,0.01270855],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.02589005,"threshold_uncertainty_score":0.1369213,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4389951978","doi":"10.2217/imt-2023-0201","title":"Epicutaneous Immunotherapy with Viaskin Peanut in toddlers: a plain language summary","year":2023,"lang":"en","type":"letter","venue":"Immunotherapy","topic":"Food Allergy and Anaphylaxis Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"Genentech; UnitedHealth Group; Thermo Fisher Scientific; Food Allergy Research and Education","keywords":"Immunotherapy; Oral immunotherapy; Medicine; Psychology; Immunology; Immune system","authors":[{"name":"David R. Stukus","is_ca":false},{"name":"Ruchi S. Gupta","is_ca":false},{"name":"Douglas P. Mack","is_ca":true},{"name":"Lianne Mandelbaum","is_ca":false},{"name":"Dareen Siri","is_ca":false},{"name":"Vivian Hernandez‐Trujillo","is_ca":false},{"name":"Hugh A. Sampson","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01674315307908023,"gpt":0.2877756399452742,"spread":0.271032486866194,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002276597,0.0006599771,0.001408909,0.001122906,0.0003534961,0.002226964,0.0006530539,0.001463559,0.009505097],"category_scores_gemma":[0.008838186,0.0002615432,0.001084688,0.0008129749,0.0004309983,0.001290368,0.0005585712,0.002289862,0.00347694],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001525348,"about_ca_system_score_gemma":0.00229818,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004314508,"about_ca_topic_score_gemma":0.004066925,"domain_scores_codex":[0.9988396,0.0003873918,0.0004338175,0.00006279735,0.0001900926,0.00008646963],"domain_scores_gemma":[0.9938792,0.002636525,0.001191473,0.00008075048,0.001915733,0.000296362],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001158119,0.0003002677,0.002279192,0.01938981,0.0002063559,0.001819945,0.0002472361,0.0001928146,0.001237183,0.001463322,0.6230771,0.3486286],"study_design_scores_gemma":[0.0005211763,0.00200698,0.008883581,0.02831134,0.0005291287,0.002977622,0.0005303886,0.0001233816,0.0007287512,0.001093813,0.9542196,0.0000741281],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"commentary","genre_scores_codex":[0.003893081,0.8192999,0.0009536316,0.1340686,0.02408382,0.0004360085,0.001984375,0.0001388425,0.01514175],"genre_scores_gemma":[0.01788944,0.8025277,0.002100077,0.1243593,0.0367985,0.0005953124,0.001971697,0.00007547062,0.01368248],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.009505097,"threshold_uncertainty_score":0.03179771,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4409178690","doi":"10.1080/1750743x.2025.2485012","title":"Effects of cannabinoids on immune checkpoint inhibitor response: CCTG pooled analysis of individual patient data","year":2025,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Calgary; Princess Margaret Cancer Centre; McMaster University; Pancreas Centre (Canada); University Health Network; Kingston Health Sciences Centre; Canadian Partnership Against Cancer","funders":"Canadian Cancer Society Research Institute; AstraZeneca","keywords":"Immune system; Medicine; Immunology; Oncology; Cancer research","authors":[{"name":"Courtney H. Coschi","is_ca":true},{"name":"Keyue Ding","is_ca":true},{"name":"Justin Tong","is_ca":true},{"name":"Dongsheng Tu","is_ca":true},{"name":"Christopher O’Callaghan","is_ca":true},{"name":"Natasha B. Leighl","is_ca":true},{"name":"Francisco Vera-Badillo","is_ca":false},{"name":"Rosalyn A. Juergens","is_ca":true},{"name":"Desirée Hao","is_ca":false},{"name":"Lesley Seymour","is_ca":true},{"name":"Daniel J. Renouf","is_ca":true},{"name":"Eric X. Chen","is_ca":true},{"name":"Pierre-Olivier Gaudreau","is_ca":true},{"name":"Andrea S. Fung","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01206976354950515,"gpt":0.2952771858467567,"spread":0.2832074222972515,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01816327,0.001117087,0.005949385,0.002583829,0.0003149711,0.001622307,0.0008205755,0.0009401655,0.002793096],"category_scores_gemma":[0.02287562,0.0004942137,0.01053453,0.003611254,0.0004092453,0.0006684519,0.0009179403,0.0007589152,0.0002364618],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001161502,"about_ca_system_score_gemma":0.001421389,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007581036,"about_ca_topic_score_gemma":0.01148622,"domain_scores_codex":[0.9804572,0.01150491,0.002257909,0.002788431,0.0022297,0.0007618397],"domain_scores_gemma":[0.9808405,0.01049341,0.004249186,0.002860302,0.001184637,0.0003719197],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.09860983,0.0001566292,0.2190751,0.007492169,0.6153855,0.0003695694,0.000165013,0.005060427,0.003197592,0.0002422577,0.004586235,0.04565964],"study_design_scores_gemma":[0.009714143,0.006551212,0.390796,0.000636129,0.5721816,0.0005894947,0.000166029,0.00651283,0.002027145,0.0008100556,0.009843255,0.000172132],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8043802,0.1438322,0.01088172,0.0006930732,0.0005934174,0.002111552,0.03193454,0.0004168618,0.005156408],"genre_scores_gemma":[0.9893559,0.002840905,0.001632586,0.000224532,0.0001617685,0.0006545072,0.004513605,0.00006162059,0.0005545274],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01816327,"threshold_uncertainty_score":0.09605777,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2067278548","doi":"10.2217/imt.11.25","title":"Research Highlights: Do Conventional Treatments for HPV-Positive Head and Neck Cancers Elicit Immunotherapeutic Type Responses?","year":2011,"lang":"en","type":"letter","venue":"Immunotherapy","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; HPV vaccines; Cancer; Human papillomavirus; Head and neck cancer; MEDLINE; Family medicine; Oncology; Internal medicine; Cervical cancer; HPV infection; Biology","authors":[{"name":"Hosam A. Kader","is_ca":true},{"name":"Darin A. Wick","is_ca":true},{"name":"John R. Webb","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1097987498157338,"gpt":0.4235713409828063,"spread":0.3137725911670726,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002834228,0.0005667893,0.00102519,0.0003615074,0.002008006,0.002684538,0.0009363403,0.02421711,0.008637206],"category_scores_gemma":[0.01570375,0.0003712603,0.0007363612,0.0005004033,0.002120518,0.003641178,0.001087215,0.0158166,0.004763952],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003452296,"about_ca_system_score_gemma":0.002415055,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001280252,"about_ca_topic_score_gemma":0.002345063,"domain_scores_codex":[0.9973936,0.001092169,0.0003088698,0.0002388537,0.0006068359,0.0003595446],"domain_scores_gemma":[0.993059,0.004621285,0.0005610582,0.0002052243,0.0009996603,0.000553799],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001889188,0.0001270856,0.002066733,0.0002944316,0.00002260309,0.006439402,0.0002871472,0.0001864963,0.001055983,0.006216105,0.9225127,0.06060239],"study_design_scores_gemma":[0.0002351247,0.000332796,0.001997427,0.0004597476,0.00005543454,0.009391354,0.001135389,0.0006395137,0.0006958015,0.0184027,0.9666013,0.00005334806],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.0009491013,0.002166087,0.0001342557,0.9845344,0.007749351,0.00001389533,0.00003419863,0.00001605829,0.004402725],"genre_scores_gemma":[0.01861227,0.006074687,0.0006526965,0.8815734,0.0822362,0.00006749993,0.00005607785,0.00002130654,0.01070589],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.02421711,"threshold_uncertainty_score":0.02889436,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4410303297","doi":"10.1080/1750743x.2025.2493039","title":"Assessing real-world treatment with SDZ ETN (an etanercept biosimilar) in people with rheumatic diseases included in the COMPACT study: a plain language summary","year":2025,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Medac; Cilag; Mylan; Celgene; Biogen; Gilead Sciences; Chugai Pharmaceutical; Celltrion; Sanofi; Eli Lilly and Company; AstraZeneca; Edwards Lifesciences; Amgen","keywords":"Biosimilar; Etanercept; Medicine; Plain language; Pharmacology; Internal medicine; Intensive care medicine; Oncology; Physical therapy; Rheumatoid arthritis; Linguistics","authors":[{"name":"Marc Schmalzing","is_ca":false},{"name":"H Kellner","is_ca":false},{"name":"Ayman Askari","is_ca":false},{"name":"Javier de Toro Santos","is_ca":false},{"name":"Julio Cesar Vazquez Perez-Coleman","is_ca":false},{"name":"Rosario Foti","is_ca":false},{"name":"Sławomir Jeka","is_ca":false},{"name":"Yannick Allanore","is_ca":false},{"name":"P. Peichl","is_ca":false},{"name":"Martin Oehri","is_ca":false},{"name":"Neil Betteridge","is_ca":false},{"name":"Cristofer Salvati","is_ca":false},{"name":"Elisa Isabel Sánchez-Romero","is_ca":false},{"name":"Ines Brueckmann","is_ca":false},{"name":"Tom Sheeran","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02248146023747329,"gpt":0.3565027595321673,"spread":0.334021299294694,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0223269,0.0007704099,0.001943741,0.001402008,0.0004709678,0.003324081,0.0006865646,0.001802794,0.01287126],"category_scores_gemma":[0.06506791,0.0004280677,0.002345991,0.001572484,0.0004960659,0.001836147,0.0009808732,0.002333993,0.003423189],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001766954,"about_ca_system_score_gemma":0.003227664,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002392235,"about_ca_topic_score_gemma":0.003734749,"domain_scores_codex":[0.975675,0.01222564,0.006782444,0.0006837709,0.00419986,0.0004333085],"domain_scores_gemma":[0.9316409,0.03620102,0.01431014,0.001436831,0.01522677,0.001184334],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.01683914,0.0008370689,0.02762489,0.05647132,0.003592049,0.000434035,0.001343454,0.0007578608,0.001549981,0.002044471,0.4703893,0.4181164],"study_design_scores_gemma":[0.0117773,0.01286022,0.1058019,0.04708631,0.005678808,0.001346831,0.00192648,0.0008754641,0.002853772,0.002993198,0.8063291,0.000470724],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.1115276,0.4214589,0.01427871,0.2144977,0.02312629,0.01534948,0.1303665,0.0009878137,0.06840699],"genre_scores_gemma":[0.3757866,0.2880418,0.0475872,0.1504003,0.0227259,0.02492643,0.06830609,0.0005031395,0.02172248],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.0223269,"threshold_uncertainty_score":0.1180773,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4413876847","doi":"10.1080/1750743x.2025.2545172","title":"Amlitelimab, an anti-OX40 ligand antibody, for atopic dermatitis: a plain language summary of STREAM-AD clinical study","year":2025,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Association of Cardiovascular Prevention and Rehabilitation; Probity Medical Research","funders":"","keywords":"Atopic dermatitis; Medicine; Antibody; Immunology; Dermatology","authors":[{"name":"Stephan Weidinger","is_ca":false},{"name":"Andrew Blauvelt","is_ca":false},{"name":"Kim Papp","is_ca":true},{"name":"Adam Reich","is_ca":false},{"name":"Chih‐Hung Lee","is_ca":false},{"name":"Margitta Worm","is_ca":false},{"name":"Charles Lynde","is_ca":true},{"name":"Yoko Kataoka","is_ca":false},{"name":"Peter Foley","is_ca":false},{"name":"Xiaodan Wei","is_ca":false},{"name":"Anne-Catherine Solente","is_ca":false},{"name":"Christine Weber","is_ca":false},{"name":"Samuel Adelman","is_ca":false},{"name":"Sonya Davey","is_ca":false},{"name":"Fabrice Hurbin","is_ca":false},{"name":"Natalie Rynkiewicz","is_ca":false},{"name":"Karl Yen","is_ca":false},{"name":"John T. O’Malley","is_ca":false},{"name":"Charlotte Bernigaud","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01741069612282447,"gpt":0.3835217972923066,"spread":0.3661111011694821,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006205499,0.0008646396,0.001562427,0.0008391416,0.0003984565,0.002032346,0.0008032512,0.001933194,0.01652839],"category_scores_gemma":[0.005456937,0.0003211645,0.002354504,0.0007784038,0.0002548098,0.001145993,0.0004519469,0.002265069,0.004849267],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008771155,"about_ca_system_score_gemma":0.00162299,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009156338,"about_ca_topic_score_gemma":0.001654163,"domain_scores_codex":[0.9980124,0.0008954672,0.0004108966,0.0001033811,0.0004779092,0.00009984425],"domain_scores_gemma":[0.995736,0.001279408,0.0005878139,0.0001128035,0.001901612,0.0003823228],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.009861502,0.001270993,0.001156054,0.01694815,0.0008076927,0.0004890518,0.0001028131,0.0002455208,0.003679863,0.001441527,0.4225033,0.5414935],"study_design_scores_gemma":[0.0175421,0.01444801,0.005871419,0.01248366,0.002323924,0.00157957,0.0001134423,0.0003635914,0.002420964,0.00139012,0.9413674,0.00009571588],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.01933013,0.7444522,0.005111448,0.09921911,0.02205195,0.01109436,0.0165034,0.0006134775,0.08162384],"genre_scores_gemma":[0.07497201,0.6383042,0.01708539,0.1367941,0.02952241,0.008563447,0.02034725,0.0002830432,0.07412823],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.01652839,"threshold_uncertainty_score":0.05529302,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4415765951","doi":"10.1080/1750743x.2025.2578164","title":"Effects of serotonergic drugs on immune checkpoint inhibitor response: a pooled analysis of individual patient data from four Canadian Cancer Trials Group (CCTG) trials","year":2025,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Calgary; Pancreas Centre (Canada); Queen's University; McMaster University; Juravinski Cancer Centre; Occupational Cancer Research Centre; Princess Margaret Cancer Centre","funders":"Canadian Cancer Society Research Institute; AstraZeneca","keywords":"Serotonergic; Pooled analysis; Context (archaeology); Clinical trial; Meta-analysis; Patient data; Cancer; Immune system","authors":[{"name":"Courtney H. Coschi","is_ca":true},{"name":"Keyue Ding","is_ca":true},{"name":"Dongsheng Tu","is_ca":true},{"name":"Christopher O’Callaghan","is_ca":true},{"name":"Natasha B. Leighl","is_ca":true},{"name":"Francisco Vera-Badillo","is_ca":false},{"name":"Rosalyn A. Juergens","is_ca":true},{"name":"Desirée Hao","is_ca":true},{"name":"Lesley Seymour","is_ca":true},{"name":"Daniel J. Renouf","is_ca":true},{"name":"Eric X. Chen","is_ca":true},{"name":"Andrea S. Fung","is_ca":true},{"name":"Pierre-Olivier Gaudreau","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04188281269778614,"gpt":0.3426528544300924,"spread":0.3007700417323063,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02088815,0.001532525,0.007490114,0.003155992,0.0005891614,0.001602661,0.0009943751,0.0009420032,0.001561743],"category_scores_gemma":[0.02268659,0.0005888369,0.007812411,0.005976173,0.0005723992,0.000597848,0.000811695,0.0007751483,0.0001289689],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003293989,"about_ca_system_score_gemma":0.003840569,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.04489815,"about_ca_topic_score_gemma":0.09690899,"domain_scores_codex":[0.9816569,0.009053274,0.002518436,0.002230668,0.003604961,0.0009357003],"domain_scores_gemma":[0.9770364,0.01032619,0.006862712,0.002067336,0.00289688,0.000810428],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.1412467,0.0001713465,0.3251098,0.008532564,0.4583429,0.0004016062,0.0002867192,0.005200085,0.002545117,0.0001927385,0.006249199,0.05172136],"study_design_scores_gemma":[0.01454387,0.006153314,0.6147339,0.0006626195,0.351478,0.0004796305,0.0001745378,0.002335332,0.0009223658,0.0003487869,0.007983614,0.0001839735],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7646656,0.1862414,0.003742042,0.0006927894,0.0002415529,0.00217167,0.03810088,0.0002069385,0.00393715],"genre_scores_gemma":[0.9773673,0.007738117,0.001462569,0.0003404924,0.0001518604,0.0009369066,0.01153786,0.00005331772,0.0004114995],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04489815,"threshold_uncertainty_score":0.1104684,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2106760394","doi":"10.2217/imt.09.33","title":"Conference Scene: 3Rd Keystone Symposium On T Regulatory Cells","year":2009,"lang":"en","type":"article","venue":"Immunotherapy","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"T-cell receptor; Biology; Antigen; Immunology; T cell; Immune system","authors":[{"name":"Alicia N. McMurchy","is_ca":true},{"name":"Megan K. Levings","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01104180238505264,"gpt":0.2303903368917766,"spread":0.2193485345067239,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003578313,0.002679707,0.001400996,0.001927799,0.002539349,0.005332951,0.001848414,0.008026313,0.06878497],"category_scores_gemma":[0.001893988,0.00062234,0.002036904,0.0009415039,0.0008627348,0.002362631,0.004117732,0.008885458,0.0241657],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002350161,"about_ca_system_score_gemma":0.004052883,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001959662,"about_ca_topic_score_gemma":0.007500092,"domain_scores_codex":[0.9986454,0.0001444044,0.00004739126,0.0001898015,0.0004546146,0.0005183564],"domain_scores_gemma":[0.9976313,0.000158672,0.00008835032,0.00005618342,0.0005710468,0.001494341],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002150542,0.00006588328,0.0001294207,0.0001840209,0.00002263947,0.0001197001,0.00002728379,0.0000896345,0.001168037,0.0010953,0.9782377,0.01864524],"study_design_scores_gemma":[0.00005504163,0.0001096808,0.0008038796,0.0001604762,0.00002917234,0.0001009591,0.00007964949,0.00008810571,0.0007298542,0.000982527,0.9968398,0.00002083373],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"other","genre_scores_codex":[0.003846011,0.0761022,0.001703744,0.1500653,0.7129186,0.0003354672,0.0009192231,0.0003169247,0.05379256],"genre_scores_gemma":[0.0251823,0.04782958,0.001804391,0.04943221,0.2964977,0.0005711656,0.001854046,0.0003825059,0.5764461],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.06878497,"threshold_uncertainty_score":0.2301086,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}